Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + H2O + phosphatidylcholine/in
ADP + phosphate + phosphatidylcholine/out
-
-
-
?
ATP + H2O + phosphatidylcholine[side 1]
ADP + phosphate + phosphatidylcholine[side 2]
-
-
-
?
1-lauroyl-2-(1'-pyrenebutyroyl)-sn-glycero-3-phosphocholine/in
1-lauroyl-2-(1'-pyrenebutyroyl)-sn-glycero-3-phosphocholine/out
-
i.e. pyrene-10-PC, development of a transbilayer lipid flip-flop assay in PLS3 proteoliposomes, overview
-
-
r
acetyl phosphate + H2O
acetate + phosphate
-
translocation of phosphatidylserine from the outer to the inner leaflet of resealed erythrocyte ghosts
-
-
?
ATP + H2O
ADP + phosphate
ATP + H2O + 1-palmitoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-glycero-3-phospho-L-serine/in
ADP + phosphate + 1-palmitoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-glycero-3-phospho-L-serine/out
-
-
-
?
ATP + H2O + 7-nitrobenz-2-oxa-1,3-diazol-4-yl-phosphatidylserine/in
ADP + phosphate + 7-nitrobenz-2-oxa-1,3-diazol-4-yl-phosphatidylserine/out
-
-
-
-
?
ATP + H2O + asolectin/out
ADP + phosphate + asolectin/in
-
-
-
-
?
ATP + H2O + carboxyfluoresceinyl-phosphatidylserine/in
ADP + phosphate + carboxyfluoresceinyl-phosphatidylserine/out
-
-
-
-
?
ATP + H2O + coumaryl-phosphatidylserine/in
ADP + phosphate + coumaryl-phosphatidylserine/out
-
-
-
-
?
ATP + H2O + galactocerebroside/out
ADP + phosphate + galactocerebroside/in
-
-
-
-
?
ATP + H2O + lactocerebroside/out
ADP + phosphate + lactocerebroside/in
-
-
-
-
?
ATP + H2O + N-methyl-dilauroylphosphatidyl-DL-serine/out
ADP + phosphate + N-methyl-dilauroylphosphatidyl-DL-serine/in
-
rapid change of cell morphology from echinocyte to stomatocyte
-
-
?
ATP + H2O + phosphatidylcholine/in
ADP + phosphate + phosphatidylcholine/out
ATP + H2O + phosphatidylethanolamine/in
ADP + phosphate + phosphatidylethanolamine/out
ATP + H2O + phosphatidylethanolamine/out
ADP + phosphate + phosphatidylethanolamine/in
ATP + H2O + phosphatidylethanolamine[side 1]
ADP + phosphate + phosphatidylethanolamine[side 2]
-
-
-
?
ATP + H2O + phosphatidylserine/in
ADP + phosphate + phosphatidylserine/out
ATP + H2O + phosphatidylserine/out
ADP + phosphate + phosphatidylserine/in
ATP + H2O + phosphatidylserine[side 1]
ADP + phosphate + phosphatidylserine[side 2]
ATP + H2O + phosphoethanolamine/in
ADP + phosphate + phosphoethanolamine/out
-
low activity
-
-
?
ATP + H2O + phospholipid/in
ADP + phosphate + phospholipid/out
-
-
-
?
ATP + H2O + phospholipid[side 1]
ADP + phosphate + phospholipid[side 2]
-
-
-
-
?
ATP + H2O + rhodamine 123/out
ADP + phosphate + rhodamine 123/in
-
-
-
-
?
ATP + H2O + sn-1,2-dilauroylphosphatidyl-D-serine/out
ADP + phosphate + sn-1,2-dilauroylphosphatidyl-D-serine/in
-
rapid change of cell morphology from echinocyte to stomatocyte
-
-
?
ATP + H2O + sn-1,2-dilauroylphosphatidyl-L-serine/out
ADP + phosphate + sn-1,2-dilauroylphosphatidyl-L-serine/in
-
rapid change of cell morphology from echinocyte to stomatocyte
-
-
?
ATP + H2O + sn-2,3-dilauroylphosphatidyl-L-serine/out
ADP + phosphate + sn-2,3-dilauroylphosphatidyl-L-serine/in
-
low activity, slow change of cell morphology from echinocyte to stomatocyte
-
-
?
ATP + H2O + sphingomyelin/out
ADP + phosphate + sphingomyelin/in
-
-
-
-
?
ATP + H2O + verapamil/out
ADP + phosphate + verapamil/in
-
highest activity
-
-
?
fluorescent labeled phosphatidylserine/outer leaflet + ATP + H2O
fluorescent labeled phosphatidylserine/inner leaflet + ADP + phosphate
-
enzyme specifically transports phosphatidylserine from the outer to the inner leaflet of the plasma membrane
-
-
?
GTP + H2O
GDP + phosphate
-
at 2 mM, 40% of the activity with 2 mM ATP
-
-
?
p-nitrophenyl phosphate + H2O
p-nitrophenol + phosphate
-
translocation of phosphatidylserine from the outer to the inner leaflet of resealed erythrocyte ghosts
-
-
?
phosphatidylcholine/out
phosphatidylcholine/in
-
-
-
-
?
phosphatidylserine/in
phosphatidylserine/out
-
-
-
-
?
phosphatidylserine/out
phosphatidylserine/in
phospholipid/in
phospholipid/out
-
unspecific bidirectional transmembrane transport of phospholipids
-
-
r
additional information
?
-
ATP + H2O
ADP + phosphate
-
-
-
?
ATP + H2O
ADP + phosphate
-
-
-
?
ATP + H2O
ADP + phosphate
-
-
-
-
?
ATP + H2O
ADP + phosphate
-
the stoichiometry between lipid translocation and ATP consumption is 1.13 for phosphatidylserine and 1.11 for phosphatidylethanolamine
-
?
ATP + H2O
ADP + phosphate
-
translocation of the aminophospholipids, phosphatidylserine and phosphatidylethanolamine, from the outer leaflet to the inner leaflet of the lipid bilayer, enzyme is involved in ATP-dependent erythrocyte shape change
-
?
ATP + H2O
ADP + phosphate
-
transport of ethanolamine at a rate 10fold slower than phosphatidylserine
-
?
ATP + H2O
ADP + phosphate
-
selectively pumps the aminophospholipids phospatidylserine and phosphatidylethanolamine from the outer to the inner monolayer of eukaryotic cells and is predominantly responsible for the asymmetric phospholipid distribution of the plasma membrane
-
?
ATP + H2O
ADP + phosphate
-
transport of phosphatidylserine
-
?
ATP + H2O
ADP + phosphate
-
transport of phosphatidylserine
-
?
ATP + H2O
ADP + phosphate
-
transport of phosphatidylserine
-
?
ATP + H2O
ADP + phosphate
-
the protein serves primarily to prevent the accumulation of phosphatidylserine on the outer surface of the cell
-
?
ATP + H2O
ADP + phosphate
-
transport of a spin-labeled phosphatidylserine analogue from the inner to the outer membrane leaflet provided Mg2+-ATP is present. The ATP-dependent transport of the phosphatidylethanolamine analogue requires the presence of an anionic phospholipid, e.g. phosphatidylinositol in the outer leaflet
-
?
ATP + H2O
ADP + phosphate
-
translocation of phosphatidylserine from the outer to the inner leaflet of resealed erythrocyte ghosts
-
?
ATP + H2O
ADP + phosphate
-
activity is stimulated twofold by addition of 2 mM ATP
-
?
ATP + H2O
ADP + phosphate
-
ATPase activity is stimulated by phosphatidylserine but not by phosphatidylcholine
-
?
ATP + H2O
ADP + phosphate
-
transport of N-methylphosphatidylserine
-
?
ATP + H2O
ADP + phosphate
-
transport of phosphatidylethanolamine
-
?
ATP + H2O
ADP + phosphate
-
a decrease in the size of the pool of flippase transportable phosphatidylethanolamine molecules causes a corresponding decrease in Mg2+-ATPase activity
-
?
ATP + H2O
ADP + phosphate
-
the initial maintenance of phospholipid asymmetry in diamide-treated erythrocytes can be solely ascribed to the action of the ATP-dependent aminophospholipid translocase
-
-
?
ATP + H2O
ADP + phosphate
-
role in aminophospholipid transport
-
-
?
ATP + H2O
ADP + phosphate
-
role of the enzyme in the control of erythrocyte shape, possibly through association with the ATP-dependent translocation of phosphatidylserine and phosphatidylethanolamine from the outer to the inner leaflet of the bilayer
-
-
?
ATP + H2O
ADP + phosphate
-
the enzyme is responsible for the inward transport of phosphatidylserine and phosphatidylethanolamine within the erythrocyte membrane
-
-
?
ATP + H2O + phosphatidylcholine/in
ADP + phosphate + phosphatidylcholine/out
-
-
-
?
ATP + H2O + phosphatidylcholine/in
ADP + phosphate + phosphatidylcholine/out
preferred substrate
-
-
?
ATP + H2O + phosphatidylethanolamine/in
ADP + phosphate + phosphatidylethanolamine/out
-
-
-
-
?
ATP + H2O + phosphatidylethanolamine/in
ADP + phosphate + phosphatidylethanolamine/out
-
-
-
?
ATP + H2O + phosphatidylethanolamine/out
ADP + phosphate + phosphatidylethanolamine/in
-
low activity, transport from the outer to the inner leaflet of the plasma membrane, the activity is regulated by Fas-, caspase 8-, and caspase 3-dependent signaling in erythrocytes with differences in old and young red blood cells, overview
-
-
?
ATP + H2O + phosphatidylethanolamine/out
ADP + phosphate + phosphatidylethanolamine/in
-
transport from the exoplasmic to the cytosolic leaflet of the plasma membrane
-
-
?
ATP + H2O + phosphatidylethanolamine/out
ADP + phosphate + phosphatidylethanolamine/in
-
low activity, transport from the outer to the inner leaflet of the plasma membrane
-
-
?
ATP + H2O + phosphatidylserine/in
ADP + phosphate + phosphatidylserine/out
-
-
-
-
?
ATP + H2O + phosphatidylserine/in
ADP + phosphate + phosphatidylserine/out
-
-
-
?
ATP + H2O + phosphatidylserine/in
ADP + phosphate + phosphatidylserine/out
-
ABCB4 mediates the efflux of phospholipids into the canalicular lumen in the presence of bile salts, and plays a crucial role in bile formation and lipid homeostasis
-
-
?
ATP + H2O + phosphatidylserine/in
ADP + phosphate + phosphatidylserine/out
-
selective ATP-dependent transport of phosphatidylserine from the outer to the inner monolayer of the membrane
-
-
?
ATP + H2O + phosphatidylserine/in
ADP + phosphate + phosphatidylserine/out
-
selective ATP-dependent transport of phosphatidylserine from the outer to the inner monolayer of the plasma membrane of erythrocytes to maintainthe lipid asymmetry, overview
-
-
?
ATP + H2O + phosphatidylserine/in
ADP + phosphate + phosphatidylserine/out
selective ATP-dependent transport of phosphatidylserine from the outer to the inner monolayer of the plasma membrane, proteins are pivotal factors in the trafficking of ATP8B1 to the plasma membrane and thus may be essential determinants of ATP8B1-related disease
-
-
?
ATP + H2O + phosphatidylserine/in
ADP + phosphate + phosphatidylserine/out
-
ABCB4 is required for ATP-dependent phosphatidylcholine secretion into the bile and to translocate phosphatidylcholine across the plasma membrane, overview
-
-
?
ATP + H2O + phosphatidylserine/in
ADP + phosphate + phosphatidylserine/out
-
selective ATP-dependent transport of phosphatidylserine from the outer to the inner monolayer of the plasma membrane
-
-
?
ATP + H2O + phosphatidylserine/in
ADP + phosphate + phosphatidylserine/out
selective ATP-dependent transport of phosphatidylserine from the outer to the inner monolayer of the plasma membrane
-
-
?
ATP + H2O + phosphatidylserine/out
ADP + phosphate + phosphatidylserine/in
-
flippase activity: transport from the outer to the inner leaflet of the plasma membrane
-
-
?
ATP + H2O + phosphatidylserine/out
ADP + phosphate + phosphatidylserine/in
-
transport from the exoplasmic to the cytosolic leaflet of the plasma membrane
-
-
?
ATP + H2O + phosphatidylserine/out
ADP + phosphate + phosphatidylserine/in
-
transport from the external leaflet of the membrane to the inner leaflet, the enzyme controls the level of phosphatidylserine exposed to the platelet surface antagonizing to the scramblase activity, overview
-
-
?
ATP + H2O + phosphatidylserine/out
ADP + phosphate + phosphatidylserine/in
-
transport from the outer to the inner leaflet of the plasma membrane, the activity is regulated by Fas-, caspase 8-, and caspase 3-dependent signaling in erythrocytes with differences in old and young red blood cells, overview
-
-
?
ATP + H2O + phosphatidylserine/out
ADP + phosphate + phosphatidylserine/in
-
7-nitro-2-1,3-benzoxadiazol-4-yl-fluorescent-labeled substrate, transport from the external leaflet of the membrane to the inner leaflet
-
-
?
ATP + H2O + phosphatidylserine/out
ADP + phosphate + phosphatidylserine/in
-
transport from the outer to the inner leaflet of the plasma membrane
-
-
?
ATP + H2O + phosphatidylserine[side 1]
ADP + phosphate + phosphatidylserine[side 2]
-
-
-
-
?
ATP + H2O + phosphatidylserine[side 1]
ADP + phosphate + phosphatidylserine[side 2]
-
-
-
?
ATP + H2O + phosphatidylserine[side 1]
ADP + phosphate + phosphatidylserine[side 2]
-
-
-
?
dATP + H2O
dADP + H2O
-
-
-
-
?
dATP + H2O
dADP + H2O
-
at 2 mM nearly as active as ATP
-
-
?
phosphatidylserine/out
phosphatidylserine/in
-
bidirectional transport, the enzyme controls the level of phosphatidylserine exposed to the platelet surface antagonizing to the aminophospholipid translocase activity, overview
-
-
r
phosphatidylserine/out
phosphatidylserine/in
-
7-nitro-2-1,3-benzoxadiazol-4-yl-fluorescent-labeled substrate, bidirectional transport
-
-
r
additional information
?
-
-
flippase recognizes multiple structural elements in its preferred lipid substrate. The lipid structural elements include a primary amine group, limited headgroup size and and sn-1,2-glycerol backbone. The presence of carboxyl group accelerates transport, but is not required for activity
-
-
?
additional information
?
-
-
the enzyme is a P-type ATPase involved in regulation of the lipid asymmetry of the cell membrane
-
-
?
additional information
?
-
-
the enzyme depends on ATP
-
-
?
additional information
?
-
-
the enzyme depends on ATP
-
-
?
additional information
?
-
-
the enzyme does not require energy supply by ATP hydrolysis
-
-
?
additional information
?
-
-
the enzyme is independent of ATP
-
-
?
additional information
?
-
-
the enzyme is independent of ATP or energy supply
-
-
?
additional information
?
-
-
glycoprotein IIb/IIIa blockade inhibits platelet aminophospholipid exposure by potentiating translocase and attenuating scramblase activity, regulation and physiological effects, overview
-
-
?
additional information
?
-
-
phospholipid scramblase 3 is involved in the regulation of tumor necrosis factor-alpha-induced apoptosis, overexpression of PLS3 enhances, whereas downregulation of PLS3 delays, TNF-R-induced apoptosis and targeting of tBid to mitochondria, as well as overexpression increases and downregulation decreases the percentage of cardiolipin on the mitochondrial surface and tBid binding capacity, overview. PLS3 is an important downstream effector of Bcl-2 and tBid in apoptosis,PLS3 regulation, overview
-
-
?
additional information
?
-
PLSCR1 acts as signaling molecule and is involved in redistribution of plasma membrane phospholipids triggered by increased cytosolic Ca2+. The enzyme plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview
-
-
?
additional information
?
-
PLSCR1 acts as signaling molecule and is involved in redistribution of plasma membrane phospholipids triggered by increased cytosolic Ca2+. The enzyme plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview
-
-
?
additional information
?
-
PLSCR1 acts as signaling molecule and is involved in redistribution of plasma membrane phospholipids triggered by increased cytosolic Ca2+. The enzyme plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview
-
-
?
additional information
?
-
PLSCR1 acts as signaling molecule and is involved in redistribution of plasma membrane phospholipids triggered by increased cytosolic Ca2+. The enzyme plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview
-
-
?
additional information
?
-
-
PLSCR1 is involved in phosphatidylserine externalization across the plasma membrane, the recombinant PLSCR1 stimulates the decatenation activity of DNA topoisomerase II isozyme alpha, overview
-
-
?
additional information
?
-
the enzyme is responsible for maintainance of the asymmetric phospholipid distribution in plasma membranes in apoptotic cells, redistribution of plasma membrane phospholipids is triggered by increased cytosolic Ca2+. The enzyme plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview
-
-
?
additional information
?
-
the enzyme is responsible for maintainance of the asymmetric phospholipid distribution in plasma membranes in apoptotic cells, redistribution of plasma membrane phospholipids is triggered by increased cytosolic Ca2+. The enzyme plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview
-
-
?
additional information
?
-
the enzyme is responsible for maintainance of the asymmetric phospholipid distribution in plasma membranes in apoptotic cells, redistribution of plasma membrane phospholipids is triggered by increased cytosolic Ca2+. The enzyme plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview
-
-
?
additional information
?
-
the enzyme is responsible for maintainance of the asymmetric phospholipid distribution in plasma membranes in apoptotic cells, redistribution of plasma membrane phospholipids is triggered by increased cytosolic Ca2+. The enzyme plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview
-
-
?
additional information
?
-
the enzyme is responsible for maintainance of the asymmetric phospholipid distribution in plasma membranes in apoptotic cells. It plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview. PLSCR3 is involved in regulation of de novo biosynthesis and resynthesis of cardiolipin in mitochondria transporting the lipid from the inner membrane to the outer mitochondrial membrane, phosphorylated PLSCR3 facilitates mitochondrial targeting of t-Bid that is an essential requirement in caspase-8 mediated apoptosis
-
-
?
additional information
?
-
the enzyme is responsible for maintainance of the asymmetric phospholipid distribution in plasma membranes in apoptotic cells. It plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview. PLSCR3 is involved in regulation of de novo biosynthesis and resynthesis of cardiolipin in mitochondria transporting the lipid from the inner membrane to the outer mitochondrial membrane, phosphorylated PLSCR3 facilitates mitochondrial targeting of t-Bid that is an essential requirement in caspase-8 mediated apoptosis
-
-
?
additional information
?
-
the enzyme is responsible for maintainance of the asymmetric phospholipid distribution in plasma membranes in apoptotic cells. It plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview. PLSCR3 is involved in regulation of de novo biosynthesis and resynthesis of cardiolipin in mitochondria transporting the lipid from the inner membrane to the outer mitochondrial membrane, phosphorylated PLSCR3 facilitates mitochondrial targeting of t-Bid that is an essential requirement in caspase-8 mediated apoptosis
-
-
?
additional information
?
-
the enzyme is responsible for maintainance of the asymmetric phospholipid distribution in plasma membranes in apoptotic cells. It plays a role in apoptosis, lipid metabolism, and thrombosis, and is involved in the Scott syndrome, detailed overview. PLSCR3 is involved in regulation of de novo biosynthesis and resynthesis of cardiolipin in mitochondria transporting the lipid from the inner membrane to the outer mitochondrial membrane, phosphorylated PLSCR3 facilitates mitochondrial targeting of t-Bid that is an essential requirement in caspase-8 mediated apoptosis
-
-
?
additional information
?
-
-
the enzyme SCRM-1 catalyzes the externalization of phosphatidylserine to the cell surface from the inner leaflet of the plasma membrane, nitrosative stress inhibits the aminophospholipid translocase resulting in phosphatidylserine externalization and macrophage engulfment, involved in inflammation, reversible by DTT, overview, macrophages can directly participate in apoptotic cell clearance by S-nitrosylation/oxidation and inhibition of APLT causing PS externalization, reversible by DTT
-
-
?
additional information
?
-
-
the enzyme SCRM-1 catalyzes the externalization of phosphatidylserine to the cell surface. Activated platelets express a procoagulant surface when the asymmetric distribution of membrane phospholipids is scrambled, leading to phosphatidylserine exposure. Phosphatidylserine expression, associated with apoptosis in nucleated cells, is reversed by APLT activity. Persistence of procoagulant surface expression is due to reduced APLT activity, regulation, overview
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, PLSCR1 is neither sufficient nor necessary for the phosphatidylserine externalization, a 1000fold increase in cytosolic Ca2+ level in response to cell activation, coagulation and apoptotic signal inactivates the ATP transporters and activates the PLSCR. This exposes PS on the cell surface, enabling the engulfment of the cell by the macrophages or binding of prothrombinase complex to activate blood coagulation cascade
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, PLSCR1 is neither sufficient nor necessary for the phosphatidylserine externalization, a 1000fold increase in cytosolic Ca2+ level in response to cell activation, coagulation and apoptotic signal inactivates the ATP transporters and activates the PLSCR. This exposes PS on the cell surface, enabling the engulfment of the cell by the macrophages or binding of prothrombinase complex to activate blood coagulation cascade
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, PLSCR1 is neither sufficient nor necessary for the phosphatidylserine externalization, a 1000fold increase in cytosolic Ca2+ level in response to cell activation, coagulation and apoptotic signal inactivates the ATP transporters and activates the PLSCR. This exposes PS on the cell surface, enabling the engulfment of the cell by the macrophages or binding of prothrombinase complex to activate blood coagulation cascade
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, PLSCR1 is neither sufficient nor necessary for the phosphatidylserine externalization, a 1000fold increase in cytosolic Ca2+ level in response to cell activation, coagulation and apoptotic signal inactivates the ATP transporters and activates the PLSCR. This exposes PS on the cell surface, enabling the engulfment of the cell by the macrophages or binding of prothrombinase complex to activate blood coagulation cascade
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, scramblase catalyzes the externalization of phosphatidylserine to the cell surface
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, scramblase catalyzes the externalization of phosphatidylserine to the cell surface
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, scramblase catalyzes the externalization of phosphatidylserine to the cell surface
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, scramblase catalyzes the externalization of phosphatidylserine to the cell surface
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, the scramblase catalyzes the externalization of phosphatidylserine to the cell surface
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, the scramblase catalyzes the externalization of phosphatidylserine to the cell surface
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, the scramblase catalyzes the externalization of phosphatidylserine to the cell surface
-
-
?
additional information
?
-
calcium-induced phospholipid scrambling is bidirectional, reversible and insensitive to phospholipid head group, the scramblase catalyzes the externalization of phosphatidylserine to the cell surface
-
-
?
additional information
?
-
recombinant ATP8B1 Physically Interacts with HA-CDC50A and HA-CDC50B, uptake of 7-nitro-2-1,3-benzoxadiazol-4-yllabeled phosphatidylcholine, phosphatidylethanolamine and sphingomyelin is not dependent on ATP8B1-CDC50 expression
-
-
?
additional information
?
-
-
substrate specificity, overview, no transport of dilauroylphosphatidylcholine, poor activity with dilauroylphosphatidylhydroxypropionate, dilauroylphosphatidylhomoserine, dilauroylphosphatidylserine-methyl ester, or sn-2,3-dilauroylphosphatidyl-D-serine
-
-
?
additional information
?
-
-
the enzyme interacts with the alpha and beta isozymes of DNA topoisomerase II binding to a specific binding site on the topo isozymes, DNA topoisomerase II isozyme alpha residues 1432-1441 are essential for binding to PLSCR1, the interaction can be inhibited by a synthetic peptide corresponding to DNA topoisomerase II isozyme alpha amino acids 1430-1441, overview
-
-
?
additional information
?
-
-
the enzyme SCRM-1 catalyzes the externalization of phosphatidylserine to the cell surface
-
-
?
additional information
?
-
-
the enzyme SCRM-1 catalyzes the externalization of phosphatidylserine to the cell surface from the inner leaflet of the plasma membrane
-
-
?
additional information
?
-
-
phosphatidylcholine, phosphatidylethanolamine, phophatidylserine, triglyceride, and cholesterol are no substrates of P-glycoprotein, ethyl acetate extracts from mouse brain homogenate exhibit weak substrate activity of P-glycoprotein
-
-
?
additional information
?
-
-
aminophospholipid translocase returns externalized phosphatidylserine to the inner membrane
-
-
?
additional information
?
-
Atp8a2 flipps fluorescent-labeled phosphatidylserine from the inner leaflet of liposomes, equivalent to the exocytoplasmic leaflet of cell membranes, to the outer leaflet, equivalent to cytoplasmic leaflet, in an ATP-dependent manner
-
-
?
additional information
?
-
dithionite NBD-lipid assay for detection of flippase activity
-
-
?
additional information
?
-
-
the enzyme does not translocalize 7-nitrobenz-2-oxa-1,3-diazol-4-yl-phosphatidylcholine or coumaryl-phosphatidylcholine
-
-
?
additional information
?
-
-
usage of 1-palmitoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]caproyl]-sn-glycero-3-phosphatidylserine as transport substrate in assays of translocated from the outer to the inner membrane leaflet
-
-
?
additional information
?
-
no substrates: phosphatidylcholine, sphingomyelin
-
-
?
additional information
?
-
no substrates: phosphatidylcholine, sphingomyelin
-
-
?
additional information
?
-
no substrates: phosphatidylcholine, sphingomyelin
-
-
?
additional information
?
-
no substrates: phosphatidylcholine, sphingomyelin
-
-
?
additional information
?
-
-
no substrates: phosphatidylcholine, sphingomyelin
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
abc-type xenobiotic transporter deficiency
ABCB4 mutations underlie hormonal cholestasis but not pediatric idiopathic gallstones.
Acute Lung Injury
Oxidative stress induces club cell proliferation and pulmonary fibrosis in Atp8b1 mutant mice.
Adenocarcinoma
Genomic array and expression analysis of frequent high-level amplifications in adenocarcinomas of the gastro-esophageal junction.
Adenocarcinoma
Identification of Phospholipid Scramblase 1 as a biomarker and it's prognostic value for Colorectal Cancer.
Adenocarcinoma
Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas.
Adenocarcinoma of Lung
Aberrant Methylation and Differential Expression of SLC2A1, TNS4, GAPDH, ATP8A2, and CASZ1 Are Associated with the Prognosis of Lung Adenocarcinoma.
Adenocarcinoma of Lung
Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues.
Adenoma
The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas.
Agranulocytosis
Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).
Alagille Syndrome
Exome sequencing reveals compound heterozygous mutations in ATP8B1 in a JAG1/NOTCH2 mutation-negative patient with clinically diagnosed Alagille syndrome.
Albuminuria
Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy.
Albuminuria
Loss of phosphatidylserine flippase ?-subunit Tmem30a in podocytes leads to albuminuria and glomerulosclerosis.
Albuminuria
PPAR{gamma}2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies.
Anaphylaxis
Phospholipid scramblase 1 amplifies anaphylactic reactions in vivo.
Anemia
ATP11C is a major flippase in human erythrocytes and its defect causes congenital hemolytic anemia.
Anemia
Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure.
Anemia
Identification and functional analyses of disease-associated P4-ATPase phospholipid flippase variants in red blood cells.
Anemia
Induction of eryptosis by cyclosporine.
Anemia
Mice deficient in the putative phospholipid flippase ATP11C exhibit altered erythrocyte shape, anemia, and reduced erythrocyte life span.
Anemia
Ribavirin-induced externalization of phosphatidylserine in erythrocytes is predominantly caused by inhibition of aminophospholipid translocase activity.
Anemia
The cytoplasmic C-terminal region of the ATP11C variant determines its localization at the polarized plasma membrane.
Anemia, Hemolytic, Congenital
ATP11C is a major flippase in human erythrocytes and its defect causes congenital hemolytic anemia.
Anemia, Hemolytic, Congenital
ATP11C T418N, a gene mutation causing congenital hemolytic anemia, reduces flippase activity due to improper membrane trafficking.
Anemia, Hemolytic, Congenital
Identification and functional analyses of disease-associated P4-ATPase phospholipid flippase variants in red blood cells.
Anemia, Sickle Cell
Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure.
Anemia, Sickle Cell
Erythrocyte ion channels in regulation of apoptosis.
Anemia, Sickle Cell
Sulphydryl modifications alter scramblase activity in murine sickle cell disease.
Anemia, Sickle Cell
Transmembrane mobility of phospholipids in sickle erythrocytes: effect of deoxygenation on diffusion and asymmetry.
Angelman Syndrome
A novel maternally expressed gene, ATP10C, encodes a putative aminophospholipid translocase associated with Angelman syndrome.
Antiphospholipid Syndrome
Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome.
Arthritis
Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis.
Astrocytoma
Phosphatase activities in human glioma cells as revealed by light and electron microscopy--a preliminary study.
Ataxia
ATP8A2-related disorders as recessive cerebellar ataxia.
Ataxia
Congenital ataxia due to novel variant in ATP8A2.
Atherosclerosis
Yeast and human P4-ATPases transport glycosphingolipids using conserved structural motifs.
Atrial Fibrillation
Large-scale whole-genome sequencing of the Icelandic population.
Atrial Flutter
Exome sequencing of a family with lone, autosomal dominant atrial flutter identifies a rare variation in ABCB4 significantly enriched in cases.
Autoimmune Diseases
Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease.
Autoimmune Diseases
Lupus-like autoimmune disease caused by a lack of Xkr8, a caspase-dependent phospholipid scramblase.
beta-Thalassemia
Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure.
Biliary Atresia
Hepatic MDR3 expression impacts lipid homeostasis and susceptibility to inflammatory bile duct obstruction in neonates.
Brain Diseases
ATP8A2-related disorders as recessive cerebellar ataxia.
Brain Diseases
Blood ammonia levels and hepatic encephalopathy induced by CCl4 in rats.
Brain Diseases
New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy.
Brain Edema
Enzyme histochemistry of rat interfascicular oligodendroglia, with special reference to 5'-nucleotidase.
Brain Ischemia
Association of protein kinase C delta and phospholipid scramblase 3 in hippocampal mitochondria correlates with neuronal vulnerability to brain ischemia.
Brain Ischemia
Spatial resolution of phospholipid scramblase 1 (PLSCR1), caspase-3 activation and DNA-fragmentation in the human hippocampus after cerebral ischemia.
Breast Neoplasms
Characterization of a selective CaMKII peptide inhibitor.
Breast Neoplasms
Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin?resistant breast cancer cells.
Breast Neoplasms
Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
Breast Neoplasms
Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Breast Neoplasms
Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro.
Carcinogenesis
Blockade of phospholipid scramblase 1 with its N-terminal domain antibody reduces tumorigenesis of colorectal carcinomas in vitro and in vivo.
Carcinogenesis
L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis.
Carcinogenesis
Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Carcinogenesis
The role of ATP8A1 in non-small cell lung cancer.
Carcinoid Tumor
Identification and characterization of CDC50A, CDC50B and CDC50C genes in silico.
Carcinoma
CDC50A plays a key role in the uptake of the anticancer drug perifosine in human carcinoma cells.
Carcinoma
Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2.
Carcinoma
Gene expression of membrane transporters: Importance for prognosis and progression of ovarian carcinoma.
Carcinoma
Human trypsinogens in the pancreas and in cancer.
Carcinoma
MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells.
Carcinoma
Phospholipid Scramblase 1 Interacts with Midkine and Regulates Hepatic Cancer Cell Proliferation and Migration.
Carcinoma
Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1.
Carcinoma
The anti-tumor alkylphospholipid perifosine is internalized by an ATP-dependent translocase activity across the plasma membrane of human KB carcinoma cells.
Carcinoma
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Carcinoma, Hepatocellular
A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature.
Carcinoma, Hepatocellular
Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds.
Carcinoma, Hepatocellular
Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cells.
Carcinoma, Hepatocellular
Chromosomal assignment and trans regulation of the tyrosine aminotransferase structural gene in hepatoma hybrid cells.
Carcinoma, Hepatocellular
Evaluation of a Novel Missense Mutation in ABCB4 Gene Causing Progressive Familial Intrahepatic Cholestasis Type 3.
Carcinoma, Hepatocellular
Isolation and characterization of the plasma membranes from rat ascites hepatomas and from normal rat livers, including newborn, regenerating, and adult livers.
Carcinoma, Hepatocellular
Phospholipid scramblase 1 mediates hepatitis C virus entry into host cells.
Carcinoma, Hepatocellular
The P4-ATPase ATP9A is a novel determinant of exosome release.
Carcinoma, Non-Small-Cell Lung
MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
The role of ATP8A1 in non-small cell lung cancer.
Carcinoma, Squamous Cell
MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells.
Cardiomegaly
The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214.
Cardiovascular Diseases
The PPAR-{gamma} Pro12Ala polymorphism associates with weight gain during GH-treatment in short children born small for gestational age.
Cerebellar Ataxia
ATP8A2-related disorders as recessive cerebellar ataxia.
Cerebellar Ataxia
Critical roles of isoleucine-364 and adjacent residues in a hydrophobic gate control of phospholipid transport by the mammalian P4-ATPase ATP8A2.
Cerebellar Ataxia
Wide spectrum of congenital anomalies including choanal atresia, malformed extremities, and brain and spinal malformations in a girl with a de novo 5.6-Mb deletion of 13q12.11-13q12.13.
Cerebral Palsy
Chorea in children: etiology, diagnostic approach and management.
Chemical and Drug Induced Liver Injury
A Complex Case of Cholestasis in a Patient with ABCB4 and ABCB11 Mutations.
Chemical and Drug Induced Liver Injury
ABCB4 / MDR3 in health and disease - at the crossroads of biochemistry and medicine.
Chemical and Drug Induced Liver Injury
ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Chemical and Drug Induced Liver Injury
Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury.
Chemical and Drug Induced Liver Injury
Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity.
Chemical and Drug Induced Liver Injury
The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
Chemical and Drug Induced Liver Injury
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Cholangiocarcinoma
A homozygous ABCB4 mutation causing an LPAC syndrome evolves into cholangiocarcinoma.
Cholangiocarcinoma
A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
Cholangiocarcinoma
Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
Cholangiocarcinoma
Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
Cholangitis
ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
Cholangitis
Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4.
Cholangitis
Multiple inflammatory-, tissue remodelling- and fibrosis genes are differentially transcribed in the livers of Abcb4 (-/ - ) mice harbouring chronic cholangitis.
Cholangitis, Sclerosing
ABCB4 deficiency: A family saga of early onset cholelithiasis, sclerosing cholangitis and cirrhosis and a novel mutation in the ABCB4 gene.
Cholangitis, Sclerosing
ABCB4 gene mutations and primary sclerosing cholangitis.
Cholangitis, Sclerosing
ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Cholangitis, Sclerosing
Effects of blocking chemokine receptor CCR1 with BX471 in two models of fibrosis prevention and rescue in mice.
Cholangitis, Sclerosing
Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Cholangitis, Sclerosing
Gene expression profiles reflect sclerosing cholangitis activity in abcb4 (-/ -) mice.
Cholangitis, Sclerosing
New insights into autoimmune cholangitis through animal models.
Cholangitis, Sclerosing
TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Choledocholithiasis
A Complex Case of Cholestasis in a Patient with ABCB4 and ABCB11 Mutations.
Cholelithiasis
A complex case of low-phospholipid-associated cholelithiasis syndrome.
Cholelithiasis
A homozygous ABCB4 mutation causing an LPAC syndrome evolves into cholangiocarcinoma.
Cholelithiasis
A letter on ABCB4 from Iceland: On the highway to liver disease.
Cholelithiasis
A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
Cholelithiasis
ABCB4 / MDR3 in health and disease - at the crossroads of biochemistry and medicine.
Cholelithiasis
ABCB4 deficiency: A family saga of early onset cholelithiasis, sclerosing cholangitis and cirrhosis and a novel mutation in the ABCB4 gene.
Cholelithiasis
ABCB4 disease: Many faces of one gene deficiency.
Cholelithiasis
ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Cholelithiasis
ABCB4 gene mutation-associated cholelithiasis in adults.
Cholelithiasis
ABCB4 mutations underlie hormonal cholestasis but not pediatric idiopathic gallstones.
Cholelithiasis
ABCB4 sequence variations in young adults with cholesterol gallstone disease.
Cholelithiasis
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed.
Cholelithiasis
Acute recurrent biliary pancreatitis associated with the ABCB4 gene mutation.
Cholelithiasis
An insertion mutation in ABCB4 is associated with gallbladder mucocele formation in dogs.
Cholelithiasis
Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
Cholelithiasis
Cholestatic liver diseases from child to adult: the diversity of MDR3 disease.
Cholelithiasis
Clinical characteristics and genetic profiles of young and adult patients with cholestatic liver disease.
Cholelithiasis
Comparison of in silico prediction and experimental assessment of ABCB4 variants identified in patients with biliary diseases.
Cholelithiasis
Expanding the mutational spectrum of the ABCB4 gene in inherited adult cholestatic liver disorders with four novel pathogenic variants.
Cholelithiasis
Familial low phospholipid-associated cholelithiasis resulting from an autosomal dominant ABCB4 mutation.
Cholelithiasis
First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
Cholelithiasis
Functional Characterization of ABCB4 Mutations Found in Low Phospholipid-Associated Cholelithiasis (LPAC).
Cholelithiasis
Genetics of gallstone disease revisited: updated inventory of human lithogenic genes.
Cholelithiasis
Genetics of gallstone disease.
Cholelithiasis
Heap of stones: an unusual cause for biliary colic and elevated liver function tests.
Cholelithiasis
Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene.
Cholelithiasis
LPAC syndrome associated with deletion of the full exon 4 in a ABCB4 genetic mutation in a patient with hepatitis C.
Cholelithiasis
Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
Cholelithiasis
Pathogenesis of cholesterol and pigment gallstones: An update.
Cholelithiasis
Pregnancy and ABCB4 gene mutation: risk of recurrent cholelithiasis.
Cholelithiasis
Prevalence of ABCB4 polymorphisms in gallstone disease in han-Chinese population.
Cholelithiasis
Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1.
Cholelithiasis
Role of common canalicular transporter gene variations in aetiology of idiopathic gallstones in childhood.
Cholelithiasis
Should patients with symptomatic cholelithiasis before 30 years of age be tested for ABCB4 gene mutations?
Cholelithiasis
Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis.
Cholelithiasis
The Multiple Facets of ABCB4 (MDR3) Deficiency.
Cholelithiasis
The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
Cholelithiasis
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Cholelithiasis
Variations of ABCB4 and ABCB11 genes are associated with primary intrahepatic stones.
Cholelithiasis
[Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholithiasis in a female patient with stop codon in the ABDC4-gene of the hepatobiliary phospholipid transporter]
Cholelithiasis
[Right upper quadrant abdominal pain and fever.]
Cholera
Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation.
Cholestasis
A Complex Case of Cholestasis in a Patient with ABCB4 and ABCB11 Mutations.
Cholestasis
A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells.
Cholestasis
A letter on ABCB4 from Iceland: On the highway to liver disease.
Cholestasis
A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion.
Cholestasis
A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults.
Cholestasis
A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
Cholestasis
A Report of 2 Infant Siblings with Progressive Intrahepatic Familial Cholestasis Type 1 and a Novel Homozygous Mutation in the ATP8B1 Gene Treated with Partial External Biliary Diversion and Liver Transplant.
Cholestasis
ABCB4 disease: Many faces of one gene deficiency.
Cholestasis
ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.
Cholestasis
ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
Cholestasis
ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Cholestasis
ABCB4 mutations underlie hormonal cholestasis but not pediatric idiopathic gallstones.
Cholestasis
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed.
Cholestasis
Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content.
Cholestasis
Adult onset of genetic disorders in bile acid transport in the liver.
Cholestasis
Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4 deficient mice.
Cholestasis
Analysis of gene mutations in children with cholestasis of undefined etiology.
Cholestasis
Assessment of Adenosine Triphosphatase Phospholipid Transporting 8B1 (ATP8B1) Function in Patients With Cholestasis With ATP8B1 Deficiency by Using Peripheral Blood Monocyte-Derived Macrophages.
Cholestasis
Assessment of ATP8B1 Deficiency in Pediatric Patients With Cholestasis Using Peripheral Blood Monocyte-Derived Macrophages.
Cholestasis
ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes.
Cholestasis
ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
Cholestasis
Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
Cholestasis
ATP8B1 gene expression is driven by a housekeeping-like promoter independent of bile acids and farnesoid X receptor.
Cholestasis
ATP8B1 is essential for maintaining normal hearing.
Cholestasis
ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy.
Cholestasis
ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations Associated with Cholestasis with Different Phenotypes and Outcomes.
Cholestasis
Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4.
Cholestasis
Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
Cholestasis
Characterization of mutations in ATP8B1 associated with hereditary cholestasis.
Cholestasis
Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice.
Cholestasis
Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice.
Cholestasis
Clinical profile and screening of exon 6 and 14 of ABCB4 gene in obstetric cholestasis patients at a tertiary care hospital in Rawalpindi, Pakistan.
Cholestasis
Co-existence of ABCB11 and DCDC2 disease: Infantile cholestasis requires both next-generation sequencing and clinical-histopathologic correlation.
Cholestasis
Common ABCB4 and ABCB11 genotypes are associated with idiopathic chronic cholestasis in adults.
Cholestasis
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
Cholestasis
Deleterious Variants in ABCC12 are Detected in Idiopathic Chronic Cholestasis and Cause Intrahepatic Bile Duct Loss in Model Organisms.
Cholestasis
Diagnosis and therapy of intrahepatic cholestasis of pregnancy.
Cholestasis
Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic hematopoietic stem cell transplantation.
Cholestasis
Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Cholestasis
Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
Cholestasis
First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
Cholestasis
Genetic variant c.711A>T in the hepatobiliary phospholipid transporter ABCB4 is associated with significant liver fibrosis.
Cholestasis
Hepatic Tmem30a deficiency causes intrahepatic cholestasis by impairing expression and localization of bile salt transporters.
Cholestasis
Heterozygous ABCB4 mutations in children with cholestatic liver disease.
Cholestasis
Hypothyroidism Associated with ATP8B1 Deficiency.
Cholestasis
IL-13 as Target to Reduce Cholestasis and Dysbiosis in Abcb4 Knockout Mice.
Cholestasis
Increased frequency of double and triple heterozygous gene variants in children with intrahepatic cholestasis.
Cholestasis
Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1.
Cholestasis
Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene.
Cholestasis
Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene.
Cholestasis
Low-GGT intrahepatic cholestasis associated with biallelic USP53 variants: clinical, histological, and ultrastructural characterization.
Cholestasis
Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities.
Cholestasis
Modification of Ca2+, Mg2+-ATPase and F-actin distribution in hepatocytes of cyclosporine A treated rats. Effect of soyabean lecithin and triacylglycerol.
Cholestasis
Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury.
Cholestasis
New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.
Cholestasis
NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations.
Cholestasis
Pharmacologic Activation of Hepatic Farnesoid X Receptor Prevents Parenteral Nutrition Associated Cholestasis in Mice.
Cholestasis
Prenatal molecular diagnosis of inherited cholestatic diseases.
Cholestasis
Presentation of Progressive Familial Intrahepatic Cholestasis Type 3 Mimicking Wilson Disease: Molecular Genetic Diagnosis and Response to Treatment.
Cholestasis
Progressive familial intrahepatic cholestasis type 1.
Cholestasis
Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up.
Cholestasis
Redistribution of Ca2+, Mg2+-ATPase activity in relation to alterations of the cytoskeleton and tight junctions in hepatocytes of cholestatic rat liver.
Cholestasis
Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
Cholestasis
Reduced spontaneous itch in mouse models of cholestasis.
Cholestasis
Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1.
Cholestasis
Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy.
Cholestasis
Severe hepatocellular dysfunction in obstetric cholestasis related to combined genetic variation in hepatobiliary transporters.
Cholestasis
Successful treatment with colestimide for a bout of cholestasis in a Japanese patient with benign recurrent intrahepatic cholestasis caused by ATP8B1 mutation.
Cholestasis
The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency.
Cholestasis
The genetics of complex cholestatic disorders.
Cholestasis
The involvement of altered vesicle transport in redistribution of Ca2+, Mg2+-ATPase in cholestatic rat liver.
Cholestasis
The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
Cholestasis
Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination.
Cholestasis
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Cholestasis
Variations of ABCB4 and ABCB11 genes are associated with primary intrahepatic stones.
Cholestasis
Whole-genome sequencing reveals large ATP8B1 deletion / duplications as "second mutations" missed by exome-based sequencing.
Cholestasis
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C.
Cholestasis
Yeast and human P4-ATPases transport glycosphingolipids using conserved structural motifs.
Cholestasis
[Childhood cholestasis and bile transporters]
Cholestasis
[Clinical feature and ATP8B1 mutation analysis of a patient with progressive familial intrahepatic cholestasis type I].
Cholestasis
[P4-ATP-ase Atp8b1/FIC1: structural properties and (patho)physiological functions].
Cholestasis
[Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholithiasis in a female patient with stop codon in the ABDC4-gene of the hepatobiliary phospholipid transporter]
Cholestasis, Intrahepatic
A case of progressive familial intrahepatic cholestasis type 1 with compound heterozygous mutations of ATP8B1.
Cholestasis, Intrahepatic
A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells.
Cholestasis, Intrahepatic
A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3.
Cholestasis, Intrahepatic
A letter on ABCB4 from Iceland: On the highway to liver disease.
Cholestasis, Intrahepatic
A Link between Intrahepatic Cholestasis and Genetic Variations in Intracellular Trafficking Regulators.
Cholestasis, Intrahepatic
A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature.
Cholestasis, Intrahepatic
A New Mutation Causing Progressive Familiar Intrahepatic Cholestasis Type 3 in Association with Autoimmune Hepatitis.
Cholestasis, Intrahepatic
A new splicing site mutation of the ABCB4 gene in intrahepatic cholestasis of pregnancy with raised serum gamma-GT.
Cholestasis, Intrahepatic
A novel ABCB11 mutation in an Iranian girl with progressive familial intrahepatic cholestasis.
Cholestasis, Intrahepatic
A novel compound heterozygous mutation in ABCB4 gene in a pedigree with progressive familial intrahepatic cholestasis 3: a case report.
Cholestasis, Intrahepatic
A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
Cholestasis, Intrahepatic
A Novel Mutation of ABCB4 in Progressive Familial Intrahepatic Cholestasis 3: Like Mother, Like Daughter.
Cholestasis, Intrahepatic
A Novel Truncation Mutation in ATP8B1 Gene in Progressive Familial Intrahepatic Cholestasis.
Cholestasis, Intrahepatic
ABCB4 / MDR3 in health and disease - at the crossroads of biochemistry and medicine.
Cholestasis, Intrahepatic
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population.
Cholestasis, Intrahepatic
ABCB4 disease: Many faces of one gene deficiency.
Cholestasis, Intrahepatic
ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Cholestasis, Intrahepatic
ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy.
Cholestasis, Intrahepatic
ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy.
Cholestasis, Intrahepatic
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed.
Cholestasis, Intrahepatic
ABCB4: Insights from pathobiology into therapy.
Cholestasis, Intrahepatic
Acute recurrent biliary pancreatitis associated with the ABCB4 gene mutation.
Cholestasis, Intrahepatic
Adult progressive intrahepatic cholestasis associated with genetic variations in ATP8B1 and ABCB11.
Cholestasis, Intrahepatic
Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
Cholestasis, Intrahepatic
An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy.
Cholestasis, Intrahepatic
An insertion mutation in ABCB4 is associated with gallbladder mucocele formation in dogs.
Cholestasis, Intrahepatic
Analysis of aberrant pre-messenger RNA splicing resulting from mutations in ATP8B1 and efficient in vitro rescue by adapted U1 small nuclear RNA.
Cholestasis, Intrahepatic
Assessment of ATP8B1 Deficiency in Pediatric Patients With Cholestasis Using Peripheral Blood Monocyte-Derived Macrophages.
Cholestasis, Intrahepatic
ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes.
Cholestasis, Intrahepatic
ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Cholestasis, Intrahepatic
ATP8B1 and ATP11C: Two Lipid Flippases Important for Hepatocyte Function.
Cholestasis, Intrahepatic
ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
Cholestasis, Intrahepatic
Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
Cholestasis, Intrahepatic
ATP8B1 gene expression is driven by a housekeeping-like promoter independent of bile acids and farnesoid X receptor.
Cholestasis, Intrahepatic
ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy.
Cholestasis, Intrahepatic
ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity.
Cholestasis, Intrahepatic
Autoimmune BSEP Disease: Disease Recurrence After Liver Transplantation for Progressive Familial Intrahepatic Cholestasis.
Cholestasis, Intrahepatic
Benign recurrent intrahepatic cholestasis (BRIC)-like episode associated with ATP8B1 variation underlying protracted cholestatic course of acute hepatitis E virus infection.
Cholestasis, Intrahepatic
Biochemical characterization of P4-ATPase mutations identified in patients with progressive familial intrahepatic cholestasis.
Cholestasis, Intrahepatic
Can genetic testing guide the therapy of cholestatic pruritus? A case of benign recurrent intrahepatic cholestasis type 2 with severe nasobiliary drainage-refractory itch.
Cholestasis, Intrahepatic
Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
Cholestasis, Intrahepatic
Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15?years after liver transplantation.
Cholestasis, Intrahepatic
Characterization of ATP8B1 gene mutations and a hot-linked mutation found in Chinese children with progressive intrahepatic cholestasis and low GGT.
Cholestasis, Intrahepatic
Characterization of urinary bile acids in a pediatric BRIC-1 patient: effect of rifampicin treatment.
Cholestasis, Intrahepatic
Chinese Children With Chronic Intrahepatic Cholestasis And High Gamma-Glutamyl Transpeptidase: Clinical Features And Association With ABCB4 Mutations.
Cholestasis, Intrahepatic
Cholestatic liver disease.
Cholestasis, Intrahepatic
Cholestatic liver diseases from child to adult: the diversity of MDR3 disease.
Cholestasis, Intrahepatic
Clinical characteristics and genetic profiles of young and adult patients with cholestatic liver disease.
Cholestasis, Intrahepatic
Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations.
Cholestasis, Intrahepatic
Clinical Variability After Partial External Biliary Diversion in Familial Intrahepatic Cholestasis 1 Deficiency.
Cholestasis, Intrahepatic
Combination of Novel c.3484G> T/p.Glu162Ter Variant in ABCB11 and c.208G> A/p.Asp70Asn Variant in ATP8B1 Are Associated with Severe Symptoms in Progressive Family Intrahepatic Cholestasis.
Cholestasis, Intrahepatic
Complementary Functions of the Flippase ATP8B1 and the Floppase ABCB4 in Maintaining Canalicular Membrane Integrity.
Cholestasis, Intrahepatic
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
Cholestasis, Intrahepatic
Current and future therapies for inherited cholestatic liver diseases.
Cholestasis, Intrahepatic
Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
Cholestasis, Intrahepatic
Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1.
Cholestasis, Intrahepatic
Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
Cholestasis, Intrahepatic
Effects of Cellular, Chemical, and Pharmacological Chaperones on the Rescue of a Trafficking-defective Mutant of the ATP-binding Cassette Transporter Proteins ABCB1/ABCB4.
Cholestasis, Intrahepatic
Evaluation of a Novel Missense Mutation in ABCB4 Gene Causing Progressive Familial Intrahepatic Cholestasis Type 3.
Cholestasis, Intrahepatic
Expanding the mutational spectrum of the ABCB4 gene in inherited adult cholestatic liver disorders with four novel pathogenic variants.
Cholestasis, Intrahepatic
Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
Cholestasis, Intrahepatic
FIC1 disease: a spectrum of intrahepatic cholestatic disorders.
Cholestasis, Intrahepatic
Fic1 is expressed at apical membranes of different epithelial cells in the digestive tract and is induced in the small intestine during postnatal development of mice.
Cholestasis, Intrahepatic
FIC1, a P-type ATPase linked to cholestatic liver disease, has homologues (ATP8B2 and ATP8B3) expressed throughout the body.
Cholestasis, Intrahepatic
First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
Cholestasis, Intrahepatic
Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate.
Cholestasis, Intrahepatic
Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).
Cholestasis, Intrahepatic
Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
Cholestasis, Intrahepatic
Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3.
Cholestasis, Intrahepatic
Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770).
Cholestasis, Intrahepatic
Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model.
Cholestasis, Intrahepatic
Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
Cholestasis, Intrahepatic
Genotype-phenotype relationships in the low-phospholipid associated cholelithiasis syndrome. A study of 156 consecutive patients.
Cholestasis, Intrahepatic
Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.
Cholestasis, Intrahepatic
Hepatic Tmem30a deficiency causes intrahepatic cholestasis by impairing expression and localization of bile salt transporters.
Cholestasis, Intrahepatic
Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy.
Cholestasis, Intrahepatic
Hepatobiliary transport in health and disease.
Cholestasis, Intrahepatic
Impaired Hepatic Uptake by Organic Anion-Transporting Polypeptides Is Associated with Hyperbilirubinemia and Hypercholanemia in Atp11c Mutant Mice.
Cholestasis, Intrahepatic
In silico investigation of the impact of synonymous variants in ABCB4 gene on mRNA stability/structure, splicing accuracy and codon usage: Potential contribution to PFIC3 disease.
Cholestasis, Intrahepatic
Increased frequency of double and triple heterozygous gene variants in children with intrahepatic cholestasis.
Cholestasis, Intrahepatic
Intestinal bile salt absorption in Atp8b1 deficient mice.
Cholestasis, Intrahepatic
Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1.
Cholestasis, Intrahepatic
Intrahepatic cholestasis in two omani siblings associated with a novel homozygous ATP8B1 mutation, c.379C>G (p.L127V).
Cholestasis, Intrahepatic
Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene.
Cholestasis, Intrahepatic
Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy.
Cholestasis, Intrahepatic
Liver disease without flipping: new functions of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1.
Cholestasis, Intrahepatic
Molecular basis of intrahepatic cholestasis.
Cholestasis, Intrahepatic
Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).
Cholestasis, Intrahepatic
Molecular characterization of exons 6, 8 and 9 of ABCB4 gene in children with Progressive Familial Intrahepatic Cholestasis type 3.
Cholestasis, Intrahepatic
Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
Cholestasis, Intrahepatic
Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4.
Cholestasis, Intrahepatic
Molecular overview of progressive familial intrahepatic cholestasis.
Cholestasis, Intrahepatic
New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.
Cholestasis, Intrahepatic
Nonsense variant of ATP8B1 gene in heterozygosis and benign recurrent intrahepatic cholestasis: A case report and review of literature.
Cholestasis, Intrahepatic
Normal pancreatic secretion in children with progressive familial intrahepatic cholestasis type 1.
Cholestasis, Intrahepatic
Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report.
Cholestasis, Intrahepatic
Novel ATP8B1 Gene Mutations in a Child with Progressive Familial Intrahepatic Cholestasis Type 1.
Cholestasis, Intrahepatic
Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis.
Cholestasis, Intrahepatic
Novel heterozygous ABCB4 gene mutation causing recurrent first-trimester intrahepatic cholestasis of pregnancy.
Cholestasis, Intrahepatic
Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis.
Cholestasis, Intrahepatic
Novel splice-site mutation in ATP8B1 results in atypical Progressive Familial Intrahepatic Cholestasis Type 1.
Cholestasis, Intrahepatic
NR1H4 analysis in patients with progressive familial intrahepatic cholestasis, drug-induced cholestasis or intrahepatic cholestasis of pregnancy unrelated to ATP8B1, ABCB11 and ABCB4 mutations.
Cholestasis, Intrahepatic
Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies.
Cholestasis, Intrahepatic
Phenotypic and Molecular Characteristics of Children with Progressive Familial Intrahepatic Cholestasis in South China.
Cholestasis, Intrahepatic
Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment.
Cholestasis, Intrahepatic
Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.
Cholestasis, Intrahepatic
Polymorphisms in ABCB11 and ATP8B1 Associated with Development of Severe Intrahepatic Cholestasis in Hodgkin's Lymphoma.
Cholestasis, Intrahepatic
Presentation of Progressive Familial Intrahepatic Cholestasis Type 3 Mimicking Wilson Disease: Molecular Genetic Diagnosis and Response to Treatment.
Cholestasis, Intrahepatic
Prevention of Cholestatic Liver Disease and Reduced Tumorigenicity in a Murine Model of PFIC Type 3 Using Hybrid AAV-piggyBac Gene Therapy.
Cholestasis, Intrahepatic
Progressive familial intrahepatic cholestasis type 1.
Cholestasis, Intrahepatic
Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up.
Cholestasis, Intrahepatic
Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity.
Cholestasis, Intrahepatic
Progressive familial intrahepatic cholestasis.
Cholestasis, Intrahepatic
Progressive familial intrahepatic cholestasis: genetic disorders of biliary transporters.
Cholestasis, Intrahepatic
Reduced spontaneous itch in mouse models of cholestasis.
Cholestasis, Intrahepatic
Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis.
Cholestasis, Intrahepatic
Resistance to Parathyroid Hormone in Two Patients with Familial Intrahepatic Cholestasis: Possible Involvement of the ATP8B1 Gene in Calcium Regulation via Parathyroid Hormone.
Cholestasis, Intrahepatic
Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1.
Cholestasis, Intrahepatic
Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy.
Cholestasis, Intrahepatic
Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis.
Cholestasis, Intrahepatic
Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models.
Cholestasis, Intrahepatic
Successful pregnancy after liver transplantation in progressive familial intrahepatic cholestasis, type 1.
Cholestasis, Intrahepatic
Successful treatment with colestimide for a bout of cholestasis in a Japanese patient with benign recurrent intrahepatic cholestasis caused by ATP8B1 mutation.
Cholestasis, Intrahepatic
Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4-/- mouse model of PFIC3.
Cholestasis, Intrahepatic
The c.504T>C (p.Asn168Asn) polymorphism in the ABCB4 gene as a predisposing factor for intrahepatic cholestasis of pregnancy in Greece.
Cholestasis, Intrahepatic
The etiology of intrahepatic cholestasis of pregnancy: towards solving a monkey puzzle.
Cholestasis, Intrahepatic
The lipid flippase heterodimer ATP8B1-CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells.
Cholestasis, Intrahepatic
The Multiple Facets of ABCB4 (MDR3) Deficiency.
Cholestasis, Intrahepatic
The phospholipid flippase ATP8B1 mediates apical localization of the cystic fibrosis transmembrane regulator.
Cholestasis, Intrahepatic
The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
Cholestasis, Intrahepatic
Two novel mutations in African and Asian children with progressive familial intrahepatic cholestasis type 3.
Cholestasis, Intrahepatic
Update on progressive familial intrahepatic cholestasis.
Cholestasis, Intrahepatic
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Cholestasis, Intrahepatic
Whole-genome sequencing reveals large ATP8B1 deletion / duplications as "second mutations" missed by exome-based sequencing.
Cholestasis, Intrahepatic
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C.
Cholestasis, Intrahepatic
[Childhood cholestasis and bile transporters]
Cholestasis, Intrahepatic
[Clinical feature and ATP8B1 mutation analysis of a patient with progressive familial intrahepatic cholestasis type I].
Cholestasis, Intrahepatic
[Progressive familial intrahepatic cholestasis type 3].
Chondrosarcoma
Identification and characterization of CDC50A, CDC50B and CDC50C genes in silico.
Chorea
Expression and functional characterization of missense mutations in ATP8A2 linked to severe neurological disorders.
Chorea
New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy.
Chorea
Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy.
Choriocarcinoma
Aminophospholipid translocase activity in JEG-3; a choriocarcinoma model of cytotrophoblast differentiation.
Colorectal Neoplasms
Antibody against N-terminal domain of phospholipid scramblase 1 induces apoptosis in colorectal cancer cells through the intrinsic apoptotic pathway.
Colorectal Neoplasms
ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancer.
Colorectal Neoplasms
Blockade of phospholipid scramblase 1 with its N-terminal domain antibody reduces tumorigenesis of colorectal carcinomas in vitro and in vivo.
Colorectal Neoplasms
Identification of ATP8B1 as a Tumor Suppressor Gene for Colorectal Cancer and Its Involvement in Phospholipid Homeostasis.
Colorectal Neoplasms
Identification of Phospholipid Scramblase 1 as a biomarker and it's prognostic value for Colorectal Cancer.
Colorectal Neoplasms
Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer.
Colorectal Neoplasms
Silencing phospholipid scramblase 1 expression by RNA interference in colorectal cancer and metastatic liver cancer.
Communicable Diseases
Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion.
Confusion
ABCB4 Disease Presenting with Cirrhosis and Copper Overload-Potential Confusion with Wilson Disease.
COVID-19
Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
Cystic Fibrosis
An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: a multicentre study.
Cystic Fibrosis
DNA Methylation at ATP11A cg11702988 Is a Biomarker of Lung Disease Severity in Cystic Fibrosis: A Longitudinal Study.
Cystic Fibrosis
Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
Cystic Fibrosis
Erythrocyte cytosolic free Ca2+ and plasma membrane Ca2+-ATPase activity in cystic fibrosis.
Cystic Fibrosis
Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770).
Cystic Fibrosis
The phospholipid flippase ATP8B1 mediates apical localization of the cystic fibrosis transmembrane regulator.
Cysts
Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2.
Cysts
Human trypsinogens in the pancreas and in cancer.
Deafness
A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells.
Deafness
Wide spectrum of congenital anomalies including choanal atresia, malformed extremities, and brain and spinal malformations in a girl with a de novo 5.6-Mb deletion of 13q12.11-13q12.13.
Demyelinating Diseases
Localization of adenosine triphosphatase activity of the endothelia in chronic relapsing experimental allergic encephalomyelitis.
Dermatomyositis
Study on the differentially expressed genes and signaling pathways in dermatomyositis using integrated bioinformatics method.
Diabetes Mellitus
Genome-Wide DNA Methylation Profiles of Phlegm-Dampness Constitution.
Diabetes Mellitus
The Pro12Ala polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinemia in subjects with type 2 diabetes mellitus.
Diabetes Mellitus, Experimental
Na+,K+-ATPase and Mg2+-ATPase activities in different regions of rat brain during alloxan diabetes.
Diabetes Mellitus, Type 2
An aminophospholipid translocase associated with body fat and type 2 diabetes phenotypes.
Diabetes Mellitus, Type 2
Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes.
Diabetes Mellitus, Type 2
Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
Diabetes Mellitus, Type 2
Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN study.
Diabetes Mellitus, Type 2
Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk.
Diabetes Mellitus, Type 2
Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese.
Diabetes Mellitus, Type 2
Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
Diabetes Mellitus, Type 2
PPAR{gamma}2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies.
Diabetes Mellitus, Type 2
The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.
Diabetes Mellitus, Type 2
The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes.
Diabetes Mellitus, Type 2
The Pro12Ala polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinemia in subjects with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
The role of PPARgamma as a thrifty gene both in mice and humans.
Diabetes Mellitus, Type 2
The role of PPARgamma in high-fat diet-induced obesity and insulin resistance.
Diabetic Nephropathies
Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
Diabetic Neuropathies
Endoneurial ATPase activity in Tangier disease and other peripheral neuropathies.
Digestive System Diseases
An insertion mutation in ABCB4 is associated with gallbladder mucocele formation in dogs.
Digestive System Diseases
Heterozygous ABCB4 mutations in children with cholestatic liver disease.
Digestive System Diseases
The Multiple Facets of ABCB4 (MDR3) Deficiency.
Digestive System Diseases
Thyroid hormone receptor ?1 stimulates ABCB4 to increase biliary phosphatidylcholine excretion in mice.
Digestive System Diseases
Trafficking and transporter disorders in pediatric cholestasis.
Digestive System Diseases
Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction.
Digestive System Diseases
[Progressive familial intrahepatic cholestasis type 3].
Dyskinesias
Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy.
Dyslipidemias
Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).
Dyslipidemias
Common Variants of ABCB4 and ABCB11 and Plasma Lipid Levels: A Study in Sib Pairs with Gallstones, and Controls.
Dyslipidemias
The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.
Dystocia
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C.
Dystonia
A novel ANO3 variant identified in a 53-year-old woman presenting with hyperkinetic dysarthria, blepharospasm, hyperkinesias, and complex motor tics.
Dystonia
Novel variants in critical domains of ATP8A2 and expansion of clinical spectrum.
Dystonia
Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy.
Encephalitis
Chorea in children: etiology, diagnostic approach and management.
Endocrine System Diseases
Lack of association of ABCB4 insertion mutation with gallbladder mucoceles in dogs.
Endometrial Neoplasms
Exome-Wide Rare Variant Analysis From the DiscovEHR Study Identifies Novel Candidate Predisposition Genes for Endometrial Cancer.
Epilepsy
Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study.
Fatty Liver
Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice.
galactokinase deficiency
Mg2+-ATPase activity in suckling rat brain regions in galactosaemia in vitro. L-Cysteine and glutathione effects.
galactokinase deficiency
The in vitro effects of galactose and its derivatives on rat brain Mg2+-ATPase activity.
galactokinase deficiency
The protective effect of L-cysteine and glutathione on the adult and aged rat brain (Na+,K+)-ATPase and Mg2+-ATPase activities in galactosemia in vitro.
Galactosemias
Mg2+-ATPase activity in suckling rat brain regions in galactosaemia in vitro. L-Cysteine and glutathione effects.
Galactosemias
The in vitro effects of galactose and its derivatives on rat brain Mg2+-ATPase activity.
Galactosemias
The protective effect of L-cysteine and glutathione on the adult and aged rat brain (Na+,K+)-ATPase and Mg2+-ATPase activities in galactosemia in vitro.
Gallbladder Diseases
ABCB4 disease: Many faces of one gene deficiency.
Gallbladder Neoplasms
ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans.
Gallbladder Neoplasms
Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.
Gallbladder Neoplasms
Genetics of gallstone disease revisited: updated inventory of human lithogenic genes.
Gallstones
ABCB4 mutations underlie hormonal cholestasis but not pediatric idiopathic gallstones.
Gallstones
ABCB4 sequence variations in young adults with cholesterol gallstone disease.
Gallstones
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed.
Gallstones
An integrated analysis of differential miRNA and mRNA expressions in human gallstones.
Gallstones
Common Variants of ABCB4 and ABCB11 and Plasma Lipid Levels: A Study in Sib Pairs with Gallstones, and Controls.
Gallstones
Future therapeutic targets for the treatment and prevention of cholesterol gallstones.
Gallstones
Genetics of gallstone disease revisited: updated inventory of human lithogenic genes.
Gallstones
Genetics of gallstone disease.
Gallstones
Heap of stones: an unusual cause for biliary colic and elevated liver function tests.
Gallstones
Mice overexpressing hepatic Abcb11 rapidly develop cholesterol gallstones.
Gallstones
Pathogenesis of cholesterol and pigment gallstones: An update.
Gallstones
Targeting the ABCB4 gene to control cholesterol homeostasis.
Gallstones
The cholangiographic features of severe forms of ABCB4/MDR3 deficiency-associated cholangiopathy in adults.
Gallstones
The Multiple Facets of ABCB4 (MDR3) Deficiency.
Gallstones
[Childhood cholestasis and bile transporters]
Gallstones
[Gallstone disease - interdisciplinary treatment].
Gallstones
[Molecular genetics of cholesterol cholelithiasis: identification of human and murine gallstone genes]
Gallstones
[Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholithiasis in a female patient with stop codon in the ABDC4-gene of the hepatobiliary phospholipid transporter]
Ganglion Cysts
[Effect of Alternanthera philoxeroides on enzymic histochemistry of oncomelania hupensis]
Genetic Diseases, Inborn
Analysis of aberrant pre-messenger RNA splicing resulting from mutations in ATP8B1 and efficient in vitro rescue by adapted U1 small nuclear RNA.
Genetic Diseases, Inborn
Nonsense variant of ATP8B1 gene in heterozygosis and benign recurrent intrahepatic cholestasis: A case report and review of literature.
Genetic Diseases, Inborn
Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis.
Genetic Diseases, Inborn
[P4-ATP-ase Atp8b1/FIC1: structural properties and (patho)physiological functions].
Glaucoma, Open-Angle
Gene expression profiles of human trabecular meshwork cells induced by triamcinolone and dexamethasone.
Glioblastoma
Phosphatase activities in human glioma cells as revealed by light and electron microscopy--a preliminary study.
Glioma
Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, and glioma cells.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Erythrocyte ion channels in regulation of apoptosis.
Glucosephosphate Dehydrogenase Deficiency
Erythrocyte ion channels in regulation of apoptosis.
Goiter, Nodular
Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter.
Head and Neck Neoplasms
ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth.
Hearing Loss
Phospholipid flippases: Building asymmetric membranes and transport vesicles.
Hearing Loss
Progressive familial intrahepatic cholestasis type 1.
Hearing Loss, Sensorineural
[P4-ATP-ase Atp8b1/FIC1: structural properties and (patho)physiological functions].
Heart Arrest
Spatial resolution of phospholipid scramblase 1 (PLSCR1), caspase-3 activation and DNA-fragmentation in the human hippocampus after cerebral ischemia.
Heart Failure
Comparison of heart sarcolemmal enzyme activities in normal and cardiomyopathic (UM-X7.1) hamsters.
Heart Failure
The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214.
Hemorrhagic Fever, Ebola
Role of Transmembrane Protein 16F in the Incorporation of Phosphatidylserine Into Budding Ebola Virus Virions.
Hepatitis
Cushing's disease presenting as cholestatic hepatitis.
Hepatitis
[Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholithiasis in a female patient with stop codon in the ABDC4-gene of the hepatobiliary phospholipid transporter]
Hepatitis B
Inhibition of Hepatitis B virus replication by Phospholipid scramblase 1 in vitro and in vivo.
Hepatitis B
Interactome map reveals phospholipid scramblase 1 as a novel regulator of hepatitis B virus x protein.
Hepatitis B
[Effect of PLSCR1 on the Antiviral Activity of IFN against HBV in HepG2 Cells].
Hepatitis B, Chronic
Interactome map reveals phospholipid scramblase 1 as a novel regulator of hepatitis B virus x protein.
Hepatitis C
LPAC syndrome associated with deletion of the full exon 4 in a ABCB4 genetic mutation in a patient with hepatitis C.
Hepatitis C
Phospholipid scramblase 1 mediates hepatitis C virus entry into host cells.
Hepatitis E
Benign recurrent intrahepatic cholestasis (BRIC)-like episode associated with ATP8B1 variation underlying protracted cholestatic course of acute hepatitis E virus infection.
Hepatoblastoma
Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4.
Hepatoblastoma
Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
Hepatolenticular Degeneration
ABCB4 Disease Presenting with Cirrhosis and Copper Overload-Potential Confusion with Wilson Disease.
Herpes Simplex
Herpes simplex viruses activate phospholipid scramblase to redistribute phosphatidylserines and Akt to the outer leaflet of the plasma membrane and promote viral entry.
Herpes Zoster
A novel aminophospholipid transporter exclusively expressed in spermatozoa is required for membrane lipid asymmetry and normal fertilization.
HIV Infections
Molecular underpinning of intracellular pH regulation on TMEM16F.
Hodgkin Disease
Polymorphisms in ABCB11 and ATP8B1 Associated with Development of Severe Intrahepatic Cholestasis in Hodgkin's Lymphoma.
Homocystinuria
Inhibition of Na+, K+-ATPase activity by the metabolites accumulating in homocystinuria.
Hyperbilirubinemia, Hereditary
ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes.
Hypercholesterolemia
ABCB4 mediates diet-induced hypercholesterolemia in laboratory opossums.
Hyperkinesis
Expression and functional characterization of missense mutations in ATP8A2 linked to severe neurological disorders.
Hyperkinesis
Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy.
Hypersensitivity
An unexpectedly high degree of specialization and a widespread involvement in sterol metabolism among the C. elegans putative aminophospholipid translocases.
Hypersensitivity
Phospholipid scramblase 1 amplifies anaphylactic reactions in vivo.
Hypersensitivity
The haploinsufficiency profile of ?-hederin suggests a caspofungin-like antifungal mode of action.
Hypertension
Association of pro12Ala polymorphism in the peroxisome proliferative-activated receptor gamma2 gene with obesity and hypertension in Korean women.
Hypertension
Homozygosity for the Ala allele of the PPAR?2 Pro12Ala polymorphism is associated with reduced risk of coronary artery disease.
Hypertension
Mitochondrial function in heart and kidney of spontaneously hypertensive rats: influence of captopril treatment.
Hypertension
Pro12Ala polymorphism in PPAR gamma 2 associated with essential hypertension in Chinese nonagenarians/centenarians.
Hypertriglyceridemia
PPARgamma mRNA expression is reduced in peripheral blood mononuclear cells after fat overload in patients with metabolic syndrome.
Hypertriglyceridemia
Pro12Ala Sequence Variant of the PPARG Gene Is Associated with Postprandial Hypertriglyceridemia in Non-E3/E3 Patients with the Metabolic Syndrome.
Hypoglycemia
Reduced Mg2+-ATPase activity in the hypoglycemic adult rat brain.
Hypoparathyroidism
X-linked hypoparathyroidism region on Xq27 is evolutionarily conserved with regions on 3q26 and 13q34 and contains a novel P-type ATPase.
Hypothyroidism
Hypothyroidism Associated with ATP8B1 Deficiency.
Ichthyosis, Lamellar
Lipid transport by mammalian ABC proteins.
Infections
Human phospholipid scramblase 1 interacts with and regulates transactivation of HTLV-1 Tax.
Infections
Inhibition of Hepatitis B virus replication by Phospholipid scramblase 1 in vitro and in vivo.
Infections
Interaction of the phospholipid scramblase 1 with HIV-1 Tat results in the repression of Tat-dependent transcription.
Infections
Interactome map reveals phospholipid scramblase 1 as a novel regulator of hepatitis B virus x protein.
Infections
Membrane Potential Is Required for MurJ Function.
Infections
The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane.
Infections
Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1.
Infections
Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species.
Infections
Use of Synthetic Hybrid Strains To Determine the Role of Replicon 3 in Virulence of the Burkholderia cepacia Complex.
Influenza, Human
Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses.
Influenza, Human
Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.
Influenza, Human
Phospholipid scramblase 1 interacts with influenza A virus NP, impairing its nuclear import and thereby suppressing virus replication.
Influenza, Human
Time-Resolved Systems Medicine Reveals Viral Infection-Modulating Host Targets.
Insulin Resistance
Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).
Insulin Resistance
Advances in Exercise, Fitness, and Performance Genomics in 2015.
Insulin Resistance
Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
Insulin Resistance
Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
Insulin Resistance
Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
Insulin Resistance
Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men.
Insulin Resistance
Genome-Wide DNA Methylation Profiles of Phlegm-Dampness Constitution.
Insulin Resistance
Inverse effects of the PPAR(gamma)2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites. The CARDIA study.
Insulin Resistance
Lipidomic and metabolic changes in the P4-type ATPase ATP10D deficient C57BL/6J wild type mice upon rescue of ATP10D function.
Insulin Resistance
Maternal Intake of n-3 Polyunsaturated Fatty Acids During Pregnancy Is Associated With Differential Methylation Profiles in Cord Blood White Cells.
Insulin Resistance
P4 ATPases - Lipid flippases and their role in disease.
Insulin Resistance
PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population.
Insulin Resistance
PPAR-gamma2 Pro12Ala polymorphism in the population of obese and non-obese men of the city of Wroclaw.
Insulin Resistance
Pro12Ala substitution in peroxisome proliferator-activated receptor gamma 2 is associated with low adiponectin concentrations in young Japanese men.
Insulin Resistance
The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.
Insulin Resistance
The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.
Insulin Resistance
The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.
Insulin Resistance
The Pro12Ala polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinemia in subjects with type 2 diabetes mellitus.
Intellectual Disability
Critical roles of isoleucine-364 and adjacent residues in a hydrophobic gate control of phospholipid transport by the mammalian P4-ATPase ATP8A2.
Intellectual Disability
Expression and functional characterization of missense mutations in ATP8A2 linked to severe neurological disorders.
Intellectual Disability
Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion.
Intellectual Disability
New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy.
Intellectual Disability
Novel variants in critical domains of ATP8A2 and expansion of clinical spectrum.
Intellectual Disability
Phospholipid flippase ATP8A2 is required for normal visual and auditory function and photoreceptor and spiral ganglion cell survival.
Leishmaniasis
In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
Leishmaniasis, Visceral
Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis.
Leukemia
Antileukemic roles of human phospholipid scramblase 1 gene, evidence from inducible PLSCR1-expressing leukemic cells.
Leukemia
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.
Leukemia
Engagement of Phospholipid Scramblase 1 in Activated Cells: IMPLICATION FOR PHOSPHATIDYLSERINE EXTERNALIZATION AND EXOCYTOSIS.
Leukemia
Identity of human normal counterpart (MmTRA1b) of mouse leukemogenesis-associated gene (MmTRA1a) product as plasma membrane phospholipid scramblase and chromosome mapping of the human MmTRA1b/phospholipid scramblase gene.
Leukemia
III-10, a newly synthesized flavonoid, induced differentiation of human U937 leukemia cells via PKC? activation.
Leukemia
Oxidation of phosphatidylserine: a mechanism for plasma membrane phospholipid scrambling during apoptosis?
Leukemia
p53 controls the switch between autophagy and apoptosis through regulation of PLSCR1 in sodium selenite-treated leukemia cells.
Leukemia
Phospholipid scramblase 1.
Leukemia
Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up-regulates phospholipid scramblase 1 gene expression.
Leukemia
[Significance of PLSCR1 in Matrine Induced Differentiation of ATRA Resistant APL Cells].
Leukemia, Myeloid
MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia.
Leukemia, Myeloid, Acute
Maesopsin 4-O-beta-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemia.
Leukemia, Myeloid, Acute
MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia.
Leukemia, Myeloid, Acute
PLSCR1/IP3R1/Ca(2+) axis contributes to differentiation of primary AML cells induced by wogonoside.
Leukemia, Promyelocytic, Acute
[Significance of PLSCR1 in Matrine Induced Differentiation of ATRA Resistant APL Cells].
Leukemia, T-Cell
Human phospholipid scramblase 1 interacts with and regulates transactivation of HTLV-1 Tax.
Leukemia, T-Cell
Maesopsin 4-O-beta-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemia.
Liver Cirrhosis
A letter on ABCB4 from Iceland: On the highway to liver disease.
Liver Cirrhosis
ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.
Liver Cirrhosis
Effects of blocking chemokine receptor CCR1 with BX471 in two models of fibrosis prevention and rescue in mice.
Liver Cirrhosis
Genetic variant c.711A>T in the hepatobiliary phospholipid transporter ABCB4 is associated with significant liver fibrosis.
Liver Cirrhosis
TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Liver Cirrhosis
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Liver Cirrhosis
Vitamin D modulates biliary fibrosis in ABCB4-deficient mice.
Liver Cirrhosis, Biliary
A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
Liver Cirrhosis, Biliary
ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Liver Cirrhosis, Biliary
Acute recurrent biliary pancreatitis associated with the ABCB4 gene mutation.
Liver Cirrhosis, Biliary
An insertion mutation in ABCB4 is associated with gallbladder mucocele formation in dogs.
Liver Cirrhosis, Biliary
Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
Liver Cirrhosis, Biliary
Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis.
Liver Cirrhosis, Biliary
Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
Liver Diseases
A "forward genomics" approach links genotype to phenotype using independent phenotypic losses among related species.
Liver Diseases
A Heterozygous ABCB4, RUNDC3B, and ABCB1 Deletion Associated With Severe Cholestatic Liver Disease in Adulthood.
Liver Diseases
A letter on ABCB4 from Iceland: On the highway to liver disease.
Liver Diseases
A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion.
Liver Diseases
A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults.
Liver Diseases
A New Mutation Causing Progressive Familiar Intrahepatic Cholestasis Type 3 in Association with Autoimmune Hepatitis.
Liver Diseases
ABCB4 disease: Many faces of one gene deficiency.
Liver Diseases
ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Liver Diseases
ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.
Liver Diseases
ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
Liver Diseases
ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Liver Diseases
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed.
Liver Diseases
Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice.
Liver Diseases
Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content.
Liver Diseases
An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: a multicentre study.
Liver Diseases
Analysis of aberrant pre-messenger RNA splicing resulting from mutations in ATP8B1 and efficient in vitro rescue by adapted U1 small nuclear RNA.
Liver Diseases
ATP8B1 and ATP11C: Two Lipid Flippases Important for Hepatocyte Function.
Liver Diseases
Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
Liver Diseases
Biochemical characterization of P4-ATPase mutations identified in patients with progressive familial intrahepatic cholestasis.
Liver Diseases
Cholestatic liver diseases from child to adult: the diversity of MDR3 disease.
Liver Diseases
Current and future therapies for inherited cholestatic liver diseases.
Liver Diseases
Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
Liver Diseases
Expanding the mutational spectrum of the ABCB4 gene in inherited adult cholestatic liver disorders with four novel pathogenic variants.
Liver Diseases
Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Liver Diseases
Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).
Liver Diseases
Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
Liver Diseases
Functional Rescue of Trafficking-Impaired ABCB4 Mutants by Chemical Chaperones.
Liver Diseases
Genetic determinants of cholangiopathies: Molecular and systems genetics.
Liver Diseases
Genetics of gallstone disease revisited: updated inventory of human lithogenic genes.
Liver Diseases
Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.
Liver Diseases
Hepatic MDR3 expression impacts lipid homeostasis and susceptibility to inflammatory bile duct obstruction in neonates.
Liver Diseases
Heterozygous ABCB4 mutations in children with cholestatic liver disease.
Liver Diseases
In silico investigation of the impact of synonymous variants in ABCB4 gene on mRNA stability/structure, splicing accuracy and codon usage: Potential contribution to PFIC3 disease.
Liver Diseases
Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1.
Liver Diseases
Large-scale whole-genome sequencing of the Icelandic population.
Liver Diseases
Linking phospholipid flippases to vesicle-mediated protein transport.
Liver Diseases
Lipid flopping in the liver.
Liver Diseases
Liver disease associated with canalicular transport defects: current and future therapies.
Liver Diseases
Liver disease without flipping: new functions of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1.
Liver Diseases
Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4.
Liver Diseases
P4 ATPases - Lipid flippases and their role in disease.
Liver Diseases
Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.
Liver Diseases
Phospholipid flippases: Building asymmetric membranes and transport vesicles.
Liver Diseases
Possible Phenylacetate Hepatotoxicity During 4-Phenylbutyrate Therapy of Byler Disease.
Liver Diseases
Prevention of Cholestatic Liver Disease and Reduced Tumorigenicity in a Murine Model of PFIC Type 3 Using Hybrid AAV-piggyBac Gene Therapy.
Liver Diseases
Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis.
Liver Diseases
Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1.
Liver Diseases
Small animal models of hepatocyte transplantation.
Liver Diseases
Strain background modifies phenotypes in the ATP8B1-deficient mouse.
Liver Diseases
Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4-/- mouse model of PFIC3.
Liver Diseases
The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm.
Liver Diseases
The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
Liver Diseases
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Liver Failure
Assessment of ATP8B1 Deficiency in Pediatric Patients With Cholestasis Using Peripheral Blood Monocyte-Derived Macrophages.
Liver Failure
Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4 ATPases.
Liver Neoplasms
ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
Liver Neoplasms
Phospholipid Scramblase 1 Interacts with Midkine and Regulates Hepatic Cancer Cell Proliferation and Migration.
Liver Neoplasms
RNA interference-mediated downregulation of phospholipid scramblase 1 expression in primary liver cancer in vitro.
Liver Neoplasms
Silencing phospholipid scramblase 1 expression by RNA interference in colorectal cancer and metastatic liver cancer.
Lung Diseases
DNA Methylation at ATP11A cg11702988 Is a Biomarker of Lung Disease Severity in Cystic Fibrosis: A Longitudinal Study.
Lung Diseases
Global gene profiling of aging lungs in Atp8b1 mutant mice.
Lung Injury
Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia.
Lung Injury
Effect and mechanism of phospholipid scramblase 4 (PLSCR4) on lipopolysaccharide (LPS)-induced injury to human pulmonary microvascular endothelial cells.
Lung Neoplasms
ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth.
Lung Neoplasms
Long non-coding RNA LINC00641 suppresses non-small-cell lung cancer by sponging miR-424-5p to upregulate PLSCR4.
Lung Neoplasms
MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer.
Lung Neoplasms
The role of ATP8A1 in non-small cell lung cancer.
Lung Neoplasms
[Ca2+, Mg2+-ATPase activity of the erythrocyte membrane in patients with lung cancer]
Lupus Erythematosus, Systemic
Increased expression of phospholipid scramblase 1 in monocytes from patients with systemic lupus erythematosus.
Lymphatic Metastasis
The role of ATP8A1 in non-small cell lung cancer.
Lymphoma
No radiosensitivity-related change in plasma membrane properties in X- or gamma-irradiated L5178Y-R and L5178Y-S cells.
Lymphoma
Oxidation of phosphatidylserine: a mechanism for plasma membrane phospholipid scrambling during apoptosis?
Lymphoma
Phospholipid flippases enable precursor B cells to flee engulfment by macrophages.
Lymphoma
Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma.
Lymphoma, Follicular
Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
Lymphoma, Mantle-Cell
Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma.
Malaria
A malaria parasite phospholipid flippase safeguards midgut traversal of ookinetes for mosquito transmission.
Malaria
ATP2, The essential P4-ATPase of malaria parasites, catalyzes lipid-stimulated ATP hydrolysis in complex with a Cdc50 ?-subunit.
Malaria
Identification and characterisation of a phospholipid scramblase in the malaria parasite Plasmodium falciparum.
Malaria
Plasmodium falciparum Guanylyl Cyclase-Alpha and the Activity of Its Appended P4-ATPase Domain Are Essential for cGMP Synthesis and Blood-Stage Egress.
Melanoma
Characterization of Mg2+-ATPase activity in isolated B16 murine melanoma melanosomes.
Melanoma
Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.
Melanoma
Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.
Melanoma
Tumor suppressor and growth regulatory genes are overexpressed in severe early-onset preeclampsia--an array study on case-specific human preeclamptic placental tissue.
Meningioma
Identification and characterization of CDC50A, CDC50B and CDC50C genes in silico.
Metabolic Diseases
Genome-wide Transcriptional Sequencing Identifies Novel Mutations in Metabolic Genes in Human Hepatocellular Carcinoma.
Metabolic Syndrome
Mobilization of pro-inflammatory lipids in obese Plscr3-deficient mice.
Metabolic Syndrome
PPARgamma mRNA expression is reduced in peripheral blood mononuclear cells after fat overload in patients with metabolic syndrome.
Microcephaly
Biallelic truncating variants in ATP9A cause a novel neurodevelopmental disorder involving postnatal microcephaly and failure to thrive.
Mononeuropathies
Endoneurial ATPase activity in Tangier disease and other peripheral neuropathies.
Movement Disorders
Expression and functional characterization of missense mutations in ATP8A2 linked to severe neurological disorders.
Movement Disorders
Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy.
Mucocele
An insertion mutation in ABCB4 is associated with gallbladder mucocele formation in dogs.
Mucocele
Lack of association of ABCB4 insertion mutation with gallbladder mucoceles in dogs.
Multiple Myeloma
Translocation t(11;14) (q13;q32) and genomic imbalances in multi-ethnic multiple myeloma patients: a Malaysian study.
Muscle Hypotonia
Expression and functional characterization of missense mutations in ATP8A2 linked to severe neurological disorders.
Muscle Hypotonia
Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion.
Muscle Hypotonia
New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy.
Muscle Hypotonia
Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy.
Muscular Diseases
Conformational behavior of polyalanine peptides with and without protecting groups of varying chain lengths: population of PP-II structure!
Muscular Dystrophies
[Na+ + K+] Mg2+-ATPase of muscle plasma membranes in Duchenne muscular dystrophy.
Muscular Dystrophy, Duchenne
[Na+ + K+] Mg2+-ATPase of muscle plasma membranes in Duchenne muscular dystrophy.
Muscular Dystrophy, Oculopharyngeal
Conformational behavior of polyalanine peptides with and without protecting groups of varying chain lengths: population of PP-II structure!
Myocardial Infarction
A gene variant in the Atp10d gene associates with atherosclerotic indices in Japanese elderly population.
Myocardial Infarction
Ala12 variant of the peroxisome proliferator-activated receptor-gamma gene (PPARG) is associated with higher polyunsaturated fat in adipose tissue and attenuates the protective effect of polyunsaturated fat intake on the risk of myocardial infarction.
Myocardial Infarction
Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study.
Myocardial Infarction
Yeast and human P4-ATPases transport glycosphingolipids using conserved structural motifs.
Nasopharyngeal Carcinoma
Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription.
Neoplasm Metastasis
ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancer.
Neoplasm Metastasis
Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Neoplasm Metastasis
Phospholipid Scramblase 1 Interacts with Midkine and Regulates Hepatic Cancer Cell Proliferation and Migration.
Neoplasm Metastasis
The role of ATP8A1 in non-small cell lung cancer.
Neoplasms
A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness.
Neoplasms
A genetic strategy involving a glycosyltransferase promoter and a lipid translocating enzyme to eliminate cancer cells.
Neoplasms
A letter on ABCB4 from Iceland: On the highway to liver disease.
Neoplasms
A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature.
Neoplasms
ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Neoplasms
ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth.
Neoplasms
ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
Neoplasms
Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.
Neoplasms
ATP11B mediates platinum resistance in ovarian cancer.
Neoplasms
Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter.
Neoplasms
Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice.
Neoplasms
Biomarker development, from bench to bedside.
Neoplasms
Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
Neoplasms
Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2.
Neoplasms
Differences in Transcript Levels of ABC Transporters Between Pancreatic Adenocarcinoma and Nonneoplastic Tissues.
Neoplasms
Endosomal phosphatidylserine is critical for the YAP signalling pathway in proliferating cells.
Neoplasms
Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
Neoplasms
Hepatobiliary transporter expression in human hepatocellular carcinoma.
Neoplasms
Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen.
Neoplasms
Human trypsinogens in the pancreas and in cancer.
Neoplasms
Identification and characterization of CDC50A, CDC50B and CDC50C genes in silico.
Neoplasms
Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
Neoplasms
Identification of ATP8B1 as a Tumor Suppressor Gene for Colorectal Cancer and Its Involvement in Phospholipid Homeostasis.
Neoplasms
Identification of Phospholipid Scramblase 1 as a biomarker and it's prognostic value for Colorectal Cancer.
Neoplasms
Induction of PLSCR1 in a STING/IRF3-Dependent Manner upon Vector Transfection in Ovarian Epithelial Cells.
Neoplasms
Interactions between HIV-1 Tat and KSHV.
Neoplasms
L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis.
Neoplasms
Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer.
Neoplasms
Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities.
Neoplasms
Mitophagy Induced by Mitochondrial Function Damage in Chicken Kidney Exposed to Cr(VI).
Neoplasms
MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells.
Neoplasms
Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma.
Neoplasms
Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Neoplasms
Nuclear interactions of topoisomerase II alpha and beta with phospholipid scramblase 1.
Neoplasms
Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Neoplasms
Phosphatidylserine: A cancer cell targeting biomarker.
Neoplasms
Phospholipid scramblase 1.
Neoplasms
Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas.
Neoplasms
RNA interference-mediated downregulation of phospholipid scramblase 1 expression in primary liver cancer in vitro.
Neoplasms
Role of Phospholipid Scramblase 3 in the Regulation of Tumor Necrosis Factor-alpha-Induced Apoptosis.
Neoplasms
Senescent Stromal Cells Promote Cancer Resistance through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles.
Neoplasms
Silencing phospholipid scramblase 1 expression by RNA interference in colorectal cancer and metastatic liver cancer.
Neoplasms
Snail interacts with hPLSCR1 promoter and down regulates its expression in IMR-32.
Neoplasms
Sorcin, a calcium binding protein involved in the multidrug resistance mechanisms in cancer cells.
Neoplasms
Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1.
Neoplasms
The potent immunosuppressive cyclosporin FR901459 inhibits the human P-glycoprotein and formyl peptide receptor functions.
Neoplasms
TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Neoplasms
Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-alpha.
Neoplasms
Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix.
Neoplasms
Tumour-associated trypsin inhibitor and tumour-associated trypsin.
Neoplasms
Two c-Myc binding sites are crucial in upregulating the expression of human phospholipid scramblase 1 gene.
Neoplasms
Valspodar: current status and perspectives.
Neoplasms
Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium.
Neoplasms
Verotoxin-1 treatment or manipulation of its receptor globotriaosylceramide (gb3) for reversal of multidrug resistance to cancer chemotherapy.
Nervous System Diseases
Expression and functional characterization of missense mutations in ATP8A2 linked to severe neurological disorders.
Neuralgia
TMEM16F Regulates Spinal Microglial Function in Neuropathic Pain States.
Neuroblastoma
Identification of phospholipid scramblase 1 as a novel interacting molecule with beta -secretase (beta -site amyloid precursor protein (APP) cleaving enzyme (BACE)).
Neurodegenerative Diseases
C-terminus of the P4-ATPase ATP8A2 functions in protein folding and regulation of phospholipid flippase activity.
Neurodegenerative Diseases
Mutations in a p-type ATPase gene cause axonal degeneration.
Neurodegenerative Diseases
Transport through recycling endosomes requires EHD1 recruitment by a phosphatidylserine translocase.
Obesity
Amerindians show no association of PPAR-?2 gene Ala12 allele and obesity: an "unthrifty" variant population genetics.
Obesity
Association of PPARG2 Pro12Ala variant with larger body mass index in Mestizo and Amerindian populations of Mexico.
Obesity
Atp10a, the mouse ortholog of the human imprinted ATP10A gene, escapes genomic imprinting.
Obesity
Genome-scale network analysis of imprinted human metabolic genes.
Obesity
Genome-Wide DNA Methylation Profiles of Phlegm-Dampness Constitution.
Obesity
Genome-wide Transcriptional Sequencing Identifies Novel Mutations in Metabolic Genes in Human Hepatocellular Carcinoma.
Obesity
Lifestyle factors modify obesity risk linked to PPARG2 and FTO variants in an elderly population: a cross-sectional analysis in the SUN Project.
Obesity
Lipidomic and metabolic changes in the P4-type ATPase ATP10D deficient C57BL/6J wild type mice upon rescue of ATP10D function.
Obesity
P4 ATPases - Lipid flippases and their role in disease.
Obesity
Phospholipid flippases: Building asymmetric membranes and transport vesicles.
Obesity
PPAR-gamma2 Pro12Ala polymorphism in the population of obese and non-obese men of the city of Wroclaw.
Obesity
The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma2 gene on skeletal muscle glucose uptake depends on obesity: a positron emission tomography study.
Obesity
Yeast and human P4-ATPases transport glycosphingolipids using conserved structural motifs.
Obesity
[Gallstone disease - interdisciplinary treatment].
Obesity, Abdominal
The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
Optic Atrophy
New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy.
Optic Atrophy
Novel variants in critical domains of ATP8A2 and expansion of clinical spectrum.
Optic Atrophy
Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy.
Osteoarthritis
Circular RNA Atp9b, a competing endogenous RNA, regulates the progression of osteoarthritis by targeting miR-138-5p.
Ovarian Cysts
Human trypsinogens in the pancreas and in cancer.
Ovarian Neoplasms
ATP11B mediates platinum resistance in ovarian cancer.
Ovarian Neoplasms
Induction of PLSCR1 in a STING/IRF3-Dependent Manner upon Vector Transfection in Ovarian Epithelial Cells.
Ovarian Neoplasms
Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.
Ovarian Neoplasms
Phospholipid Scramblase 1, an interferon-regulated gene located at 3q23, is regulated by SnoN/SkiL in ovarian cancer cells.
Ovarian Neoplasms
Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1.
Overnutrition
[Gallstone disease - interdisciplinary treatment].
Overweight
Association of PPARG2 Pro12Ala variant with larger body mass index in Mestizo and Amerindian populations of Mexico.
Overweight
Peculiarities of the effects of bile acids on atpase activity of the colon mucosa in patients with overweight and irritable bowel syndrome.
Overweight
The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
p-type phospholipid transporter deficiency
A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells.
p-type phospholipid transporter deficiency
A New Mutation Causing Progressive Familiar Intrahepatic Cholestasis Type 3 in Association with Autoimmune Hepatitis.
p-type phospholipid transporter deficiency
ABCB4 / MDR3 in health and disease - at the crossroads of biochemistry and medicine.
p-type phospholipid transporter deficiency
ABCB4 deficiency: A family saga of early onset cholelithiasis, sclerosing cholangitis and cirrhosis and a novel mutation in the ABCB4 gene.
p-type phospholipid transporter deficiency
ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
p-type phospholipid transporter deficiency
ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
p-type phospholipid transporter deficiency
Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice.
p-type phospholipid transporter deficiency
Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content.
p-type phospholipid transporter deficiency
Analysis of aberrant pre-messenger RNA splicing resulting from mutations in ATP8B1 and efficient in vitro rescue by adapted U1 small nuclear RNA.
p-type phospholipid transporter deficiency
Assessment of Adenosine Triphosphatase Phospholipid Transporting 8B1 (ATP8B1) Function in Patients With Cholestasis With ATP8B1 Deficiency by Using Peripheral Blood Monocyte-Derived Macrophages.
p-type phospholipid transporter deficiency
Assessment of ATP8B1 Deficiency in Pediatric Patients With Cholestasis Using Peripheral Blood Monocyte-Derived Macrophages.
p-type phospholipid transporter deficiency
ATP11B deficiency leads to impairment of hippocampal synaptic plasticity.
p-type phospholipid transporter deficiency
ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes.
p-type phospholipid transporter deficiency
Atp8a1 deficiency is associated with phosphatidylserine externalization in hippocampus and delayed hippocampus-dependent learning.
p-type phospholipid transporter deficiency
ATP8B1 and ATP11C: Two Lipid Flippases Important for Hepatocyte Function.
p-type phospholipid transporter deficiency
ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
p-type phospholipid transporter deficiency
Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
p-type phospholipid transporter deficiency
ATP8B1 is essential for maintaining normal hearing.
p-type phospholipid transporter deficiency
ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity.
p-type phospholipid transporter deficiency
Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
p-type phospholipid transporter deficiency
C-terminus of the P4-ATPase ATP8A2 functions in protein folding and regulation of phospholipid flippase activity.
p-type phospholipid transporter deficiency
Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
p-type phospholipid transporter deficiency
Control of Protein and Sterol Trafficking by Antagonistic Activities of a P4-ATPase and Oxysterol Binding Protein Homologue.
p-type phospholipid transporter deficiency
Current and future therapies for inherited cholestatic liver diseases.
p-type phospholipid transporter deficiency
Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
p-type phospholipid transporter deficiency
Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate.
p-type phospholipid transporter deficiency
Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).
p-type phospholipid transporter deficiency
Genetic variant c.711A>T in the hepatobiliary phospholipid transporter ABCB4 is associated with significant liver fibrosis.
p-type phospholipid transporter deficiency
Hypothyroidism Associated with ATP8B1 Deficiency.
p-type phospholipid transporter deficiency
In-silico Evaluation of Rare Codons and their Positions in the Structure of ATP8b1 Gene.
p-type phospholipid transporter deficiency
Long-term colestyramine treatment prevents cholestatic attacks in refractory benign recurrent intrahepatic cholestasis type 1 disease.
p-type phospholipid transporter deficiency
Mutational analysis of ATP8B1 in patients with chronic pancreatitis.
p-type phospholipid transporter deficiency
Pathologic Features of Hereditary Cholestatic Diseases.
p-type phospholipid transporter deficiency
Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset.
p-type phospholipid transporter deficiency
Phospholipid flippases: Building asymmetric membranes and transport vesicles.
p-type phospholipid transporter deficiency
Progressive familial intrahepatic cholestasis type 1.
p-type phospholipid transporter deficiency
Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis.
p-type phospholipid transporter deficiency
STAT3 Cooperates With Phospholipid Scramblase 2 to Suppress Type I Interferon Response.
p-type phospholipid transporter deficiency
Strain background modifies phenotypes in the ATP8B1-deficient mouse.
p-type phospholipid transporter deficiency
Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models.
p-type phospholipid transporter deficiency
Targeting the ABCB4 gene to control cholesterol homeostasis.
p-type phospholipid transporter deficiency
The cytoplasmic C-terminal region of the ATP11C variant determines its localization at the polarized plasma membrane.
p-type phospholipid transporter deficiency
The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency.
p-type phospholipid transporter deficiency
The lipid flippase heterodimer ATP8B1-CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells.
p-type phospholipid transporter deficiency
The phospholipid flippase ATP8B1 mediates apical localization of the cystic fibrosis transmembrane regulator.
p-type phospholipid transporter deficiency
TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis.
p-type phospholipid transporter deficiency
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
p-type phospholipid transporter deficiency
[Gallstone disease - interdisciplinary treatment].
p-type phospholipid transporter deficiency
[Recurrent intrahepatic cholestasis of pregnancy and chain-like choledocholithiasis in a female patient with stop codon in the ABDC4-gene of the hepatobiliary phospholipid transporter]
Pancreatic Neoplasms
Identification and characterization of CDC50A, CDC50B and CDC50C genes in silico.
Pancreatitis
Acute recurrent biliary pancreatitis associated with the ABCB4 gene mutation.
Pancreatitis
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11.
Pancreatitis
Mutational analysis of ATP8B1 in patients with chronic pancreatitis.
Pancreatitis
[Acute pancreatitis secondary to partial Multidrug resistance 3 p-glycoprotein deficit].
Pancreatitis, Chronic
Mutational analysis of ATP8B1 in patients with chronic pancreatitis.
Pancytopenia
Tmem30a plays critical roles in ensuring the survival of hematopoietic cells and leukemia cells in mice.
Papilloma
MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells.
Parasitic Diseases
A malaria parasite phospholipid flippase safeguards midgut traversal of ookinetes for mosquito transmission.
Parkinson Disease
ATP10B and the Risk for Early-Onset Parkinson's Disease.
Parkinson Disease
ATP10B and the risk for Parkinson's disease.
Parkinson Disease
ATP10B variants in Parkinson's disease: a large cohort study in Chinese mainland population.
Parkinson Disease
Genetic analysis of ATP10B for Parkinson's disease in Japan.
Parkinson Disease
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
Parkinson Disease
Reply: ATP10B and the risk for Parkinson's disease.
Parkinsonian Disorders
Reply: Segregation of ATP10B variants in families with autosomal recessive Parkinsonism.
Parkinsonian Disorders
Segregation of ATP10B variants in families with autosomal recessive parkinsonism.
Peripheral Nervous System Diseases
Endoneurial ATPase activity in Tangier disease and other peripheral neuropathies.
Phenylketonurias
In vivo effects of high phenylalanine blood levels on Na+,K+-ATPase, Mg2+-ATPase activities and biogenic amine concentrations in phenylketonuria.
Plasmacytoma
Inhibition of (Na+ + K+)-ATPase by ouabain: involvement of calcium and membrane proteins.
Pneumonia
Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia.
Prader-Willi Syndrome
Gender influences monoallelic expression of ATP10A in human brain.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Resistance to farnesyltransferase inhibitors in Bcr/Abl-positive lymphoblastic leukemia by increased expression of a novel ABC transporter homolog ATP11a.
Premature Birth
A possible role for the PPARG Pro12Ala polymorphism in preterm birth.
Proteinuria
Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
Pruritus
ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy.
Pruritus
Characterization of urinary bile acids in a pediatric BRIC-1 patient: effect of rifampicin treatment.
Pruritus
Chinese Children With Chronic Intrahepatic Cholestasis And High Gamma-Glutamyl Transpeptidase: Clinical Features And Association With ABCB4 Mutations.
Pruritus
Liver disease associated with canalicular transport defects: current and future therapies.
Pruritus
Reduced spontaneous itch in mouse models of cholestasis.
Pulmonary Fibrosis
Oxidative stress induces club cell proliferation and pulmonary fibrosis in Atp8b1 mutant mice.
Respiratory Distress Syndrome
Effect and mechanism of phospholipid scramblase 4 (PLSCR4) on lipopolysaccharide (LPS)-induced injury to human pulmonary microvascular endothelial cells.
Retinal Degeneration
DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice.
Retinal Dystrophies
Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations.
Retinitis Pigmentosa
Dimerization deficiency of enigmatic retinitis pigmentosa-linked rhodopsin mutants.
Scleroderma, Systemic
Analysis of ATP8B4 F436L missense variant in a large Systemic sclerosis cohort.
Scleroderma, Systemic
Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.
Scleroderma, Systemic
Identification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing.
Seizures
Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study.
Seizures
Microglial MERTK eliminates phosphatidylserine-displaying inhibitory post-synapses.
Seizures
[ATPase activity of subcellular rat brain fractions following hyperoxia]
Sepsis
Alterations of Na+-K+-ATPase, Ca2+-ATPase, and Mg2+-ATPase activities in erythrocyte, muscle, and liver of traumatic and septic patients.
Shock, Septic
Bioinformatic analysis identifies potential biomarkers and therapeutic targets of septic-shock-associated acute kidney injury.
Skin Diseases
Lipid transport by mammalian ABC proteins.
Skin Diseases
MAP17 is associated with the T-helper cell cytokine-induced down-regulation of filaggrin transcription in human keratinocytes.
Spinocerebellar Ataxias
TMEM16K is an interorganelle regulator of endosomal sorting.
Stargardt Disease
DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice.
Stargardt Disease
Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations.
Stargardt Disease
Lipid transport by mammalian ABC proteins.
Starvation
An unexpectedly high degree of specialization and a widespread involvement in sterol metabolism among the C. elegans putative aminophospholipid translocases.
Starvation
The type II secretion system (Xcp) of Pseudomonas putida is active and involved in the secretion of phosphatases.
Stomach Neoplasms
Effects of endoscopic submucosal dissection on post-operative early treatment effectiveness and serum TAT-2 and GP73 expression levels in patients with early gastric cancer.
Stomach Neoplasms
Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism, Helicobacter pylori infection and non-cardia gastric carcinoma in Chinese.
Stomach Neoplasms
Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.
Tangier Disease
Endoneurial ATPase activity in Tangier disease and other peripheral neuropathies.
Tangier Disease
Lipid transport by mammalian ABC proteins.
Thalassemia
Erythrocyte ion channels in regulation of apoptosis.
Thiamine Deficiency
[Effect of thiamine deficiency and excess on activity of NA+, K+, Mg2+-ATPase in plasma membranes of rat liver]
Thrombophilia
Increased expression of phospholipid scramblase 1 in monocytes from patients with systemic lupus erythematosus.
Tooth Abnormalities
Novel variants in critical domains of ATP8A2 and expansion of clinical spectrum.
Tuberculosis
A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3.
Tuberculosis
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
Urinary Bladder Neoplasms
Identification and characterization of CDC50A, CDC50B and CDC50C genes in silico.
Urolithiasis
Oxalate impairs aminophospholipid translocase activity in renal epithelial cells via oxidative stress: implications for calcium oxalate urolithiasis.
Uterine Cervical Neoplasms
Resveratrol significantly inhibits the occurrence and development of cervical cancer by regulating phospholipid scramblase 1.
Uterine Inertia
[ATPase activity and fluorescence of myometrial actomyosin in experimental uterine inertia]
Vasospasm, Intracranial
Interactive role of protein kinase C-delta with rho-kinase in the development of cerebral vasospasm in a canine two-hemorrhage model.
Vesicular Stomatitis
Inhibition of Hepatitis B virus replication by Phospholipid scramblase 1 in vitro and in vivo.
Vesicular Stomatitis
Phospholipid scramblase 1 potentiates the antiviral activity of interferon.
Virus Diseases
An inner activation gate controls TMEM16F phospholipid scrambling.
Virus Diseases
Benign recurrent intrahepatic cholestasis (BRIC)-like episode associated with ATP8B1 variation underlying protracted cholestatic course of acute hepatitis E virus infection.
Virus Diseases
Human phospholipid scramblase 1 interacts with and regulates transactivation of HTLV-1 Tax.
Virus Diseases
Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription.
Virus Diseases
Pregnancy and Interferon Tau Regulate DDX58 and PLSCR1 in the Ovine Uterus During the Peri-Implantation Period.
Virus Diseases
Time-Resolved Systems Medicine Reveals Viral Infection-Modulating Host Targets.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.